≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other and unspecified diseases of blood and blood-forming organs

DOID EFO Endpoint Browser PheWeb

D3_BLOODNAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D75.8, D75.9
  • Hospital discharge: ICD-9 — 289[8-9]
  • Hospital discharge: ICD-8 — 2899
  • Hospital discharge: excluded ICD-8 — 2899[0-1]
  • Cause of death: ICD-10 — D75.8, D75.9
  • Cause of death: ICD-9 — 289[8-9]
  • Cause of death: ICD-8 — 2899
  • Cause of death: excluded ICD-8 — 2899[0-1]

2 out of 7 registries used, show all original rules.

1031

4. Check minimum number of events

None

1031

5. Include endpoints

None

1031

6. Filter based on genotype QC (FinnGen only)

1001

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6321 3318 2939
Only index persons 5103 2725 2378
Unadjusted period prevalence (%)
Whole population 0.09 0.10 0.08
Only index persons 0.10 0.10 0.09
Median age at first event (years)
Whole population 59.07 58.15 60.11
Only index persons 57.37 55.93 59.01

-FinnGen-

Key figures

All Female Male
Number of individuals 1001 535 466
Unadjusted period prevalence (%) 0.20 0.19 0.21
Median age at first event (years) 60.58 58.53 62.93

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1031
Matched controls
10310
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01XX05
ATC
hydroxycarbamide; oral
56.1
322.3
185
40
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
75.9
307.7
197
32
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
117.9
307.7
168
17
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
4503599627370496.0
307.7
810
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
23.2
307.7
312
189
XW000
NOMESCO Finland
Bone marrow biopsy
36.0
307.7
382
166
D45
ICD-10 Finland
Polycythaemia vera
36.8
163.4
103
31
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
901.6
161.1
154
*
D75.2
ICD-10 Finland
Essential thrombocytosis
733.8
133.8
129
*
TPH00
NOMESCO Finland
Phlebotomy
42.1
85.9
52
13
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
127.1
77.1
82
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
73.3
263
822
SPAT1074
SPAT
Venesection
33.6
65.3
42
13
D75.1
ICD-10 Finland
Secondary polycythaemia
189.7
52.4
54
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
44.2
170
544
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
117.5
42.1
45
*
Z2221
NOMESCO Finland
Medical doctor
2.5
41.3
370
1872
28998
ICD-8 Finland
Other disease of blood and blood-forming organs, Alii definiti
+∞
38.8
37
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
37.3
604
3910
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.1
37.3
51
66
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
35.6
34
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
34.9
172
636
C90.0
ICD-10 Finland
Multiple myeloma
10.4
34.7
39
39
WW500
NOMESCO Finland
Blood transfusion
4.7
33.5
82
188
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
72.2
31.1
35
5
R4110
NOMESCO Finland
Physiotherapy
2.2
30.5
362
2021
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
39.4
30.4
38
10
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
8.2
28.3
38
48
D70.89
ICD-10 Finland
Neutropenic splenomegaly
77.3
26.9
30
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
99.4
26.8
29
*
D75.0
ICD-10 Finland
Familial erythrocytosis
256.1
24.8
25
*
ZXE00
NOMESCO Finland
One hour or less
2.0
24.2
443
2848
Z3226
NOMESCO Finland
Physiotherapist
2.2
23.5
229
1162
ZX120
NOMESCO Finland
Intravenous
2.7
23.0
133
531
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
21.5
222
1150
M04AA01
ATC
allopurinol; systemic
2.4
21.4
175
822
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
21.4
151
664
D64.8
ICD-10 Finland
Other specified anaemias
5.8
21.3
39
69
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
21.0
201
1008
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
22.9
20.5
29
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
19.9
347
2163
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
75.0
19.8
22
*
L01XX35
ATC
anagrelide; oral
203.8
19.6
20
*
WW200
NOMESCO Finland
Immunization
4.6
18.6
45
102
B99
ICPC
Blood/lymph/spleen disease other
30.7
18.4
24
8
L03AA02
ATC
filgrastim; parenteral
4.2
18.4
49
120
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
18.0
18.3
28
16
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
18.2
417
2815
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
17.8
266
1567
WX402
NOMESCO Finland
General anaesthesia
1.9
17.6
259
1516
B03XA01
ATC
erythropoietin; parenteral
7.5
17.4
25
34
TPH00, ,
SPAT
42.8
17.3
21
5
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
17.2
400
2700
L03AB05
ATC
interferon alfa-2b; parenteral
32.1
17.1
22
7
Z3231
NOMESCO Finland
Registered nurse
1.9
17.0
304
1892
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
16.9
110
464
H02AB06
ATC
prednisolone; systemic
1.7
16.8
513
3735
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
12.9
16.7
29
23
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
12.4
16.4
29
24
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.0
16.1
73
255
B01AB05
ATC
enoxaparin; parenteral
1.8
15.8
351
2325
189
Kela drug reimbursment
Imatinib
61.0
15.8
18
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
86.4
15.6
17
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
15.2
141
693
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
15.2
224
1306
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
6.9
14.9
23
34
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
16.8
14.8
23
14
374
Kela drug reimbursment
Ruxolitinib
81.3
14.6
16
*
B74
ICPC
Malignant neoplasm blood other
81.3
14.6
16
*
174
Kela drug reimbursment
Ruxolitinib
81.3
14.6
16
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
14.3
253
1559
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
13.9
84
341
C03CA01
ATC
furosemide; systemic
1.7
13.7
333
2243
A02BC02
ATC
pantoprazole; systemic
1.7
13.6
721
5940
L01EJ01
ATC
ruxolitinib; oral
76.2
13.6
15
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.5
13.6
47
139
316
Kela drug reimbursment
Imatinib
141.8
13.5
14
*
R50.9
ICD-10 Finland
Fever, unspecified
2.0
13.3
171
949
WX002
NOMESCO Finland
Sedation and analgesia
1.8
13.2
221
1334
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
13.1
138
712
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
22.9
12.9
18
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
12.8
367
2574
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
12.7
79
326
WX892
NOMESCO Finland
Monitored bed care
2.3
12.6
97
440
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.7
12.6
39
107
2898X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Other specified diseases of blood and blood-forming organs
+∞
12.5
12
*
212
Kela drug reimbursment
Gout
4.4
12.5
31
72
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
12.4
179
1030
L01EA01
ATC
imatinib; oral
38.0
12.2
15
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
12.0
80
341
R11
ICD-10 Finland
Nausea and vomiting
2.2
11.8
105
506
UJF92
NOMESCO Finland
Capsular endoscopy
4.0
11.8
33
84
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
11.7
215
1331
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.8
11.7
26
55
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
11.6
109
537
R4190
NOMESCO Finland
Nutritional therapy
2.9
11.5
53
187
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
11.5
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
11.4
452
3406
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
11.4
124
646
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
15.2
11.3
18
12
A04AA01
ATC
ondansetron; systemic, rectal
2.2
11.0
96
459
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.9
10.8
51
182
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
10.8
91
430
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
10.7
69
289
B03XA02
ATC
darbepoetin alfa; parenteral
3.8
10.5
32
87
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
111.1
10.4
11
*
D72.1
ICD-10 Finland
Eosinophilia
+∞
10.4
10
*
L04AD01
ATC
ciclosporin; systemic
3.9
10.3
30
79
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.6
10.2
59
235
JN4BD
NOMESCO Finland
Extensive body CT
2.0
10.1
114
602
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.8
392
2932
L03AB04
ATC
interferon alfa-2a; parenteral
26.3
9.8
13
5
J01MA12
ATC
levofloxacin; systemic
1.7
9.8
195
1230
C03DA01
ATC
spironolactone; oral
1.9
9.7
141
811
S16
ICPC
Bruise/contusion
3.1
9.7
41
138
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
9.6
331
2392
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.6
265
1819
TK800
NOMESCO Finland
Hemodialysis
3.6
9.6
31
88
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
100.9
9.4
10
*
L01XE18
ATC
[U] ruxolitinib
100.9
9.4
10
*
2899X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs
+∞
9.4
9
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
8.1
9.4
20
25
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
21.9
9.4
13
6
ZXA00
NOMESCO Finland
Right side
1.6
9.3
279
1950
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
9.3
116
634
R53
ICD-10 Finland
Malaise and fatigue
1.6
9.2
254
1741
C07AB07
ATC
bisoprolol; oral
1.5
9.2
505
4024
ZXD05
NOMESCO Finland
Urgent procedure
1.6
9.2
301
2148
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
9.0
196
1264
L01XE01
ATC
[U] imatinib
37.0
9.0
11
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
9.0
105
561
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
18.8
8.9
13
7
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
8.9
255
1763
ZXA10
NOMESCO Finland
Bilateral
1.7
8.8
190
1224
127
Kela drug reimbursment
Transplant complication
4.2
8.7
23
56
R06.0
ICD-10 Finland
Dyspnoea
1.6
8.7
286
2037
AA1AD
NOMESCO Finland
CT of head and brain
1.5
8.7
305
2204
122
Kela drug reimbursment
Aplastic anaemia
50.4
8.7
10
*
A91
ICPC
Abnormal result investigation NOS
2.2
8.6
69
319
Z2446
NOMESCO Finland
Social worker
2.2
8.6
73
346
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
8.6
71
333
J01DB01
ATC
cefalexin; oral
1.6
8.6
822
7312
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
8.5
348
2598
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
8.4
703
6051
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
8.4
101
545
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
9.5
8.3
16
17
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.2
435
3417
Z71.8
ICD-10 Finland
Other specified counselling
1.5
8.1
330
2456
R4120
NOMESCO Finland
Occupational therapy
2.1
8.1
74
361
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
10.1
8.0
15
15
J01CA04
ATC
amoxicillin; systemic
1.6
8.0
801
7117
B01AB04
ATC
dalteparin; parenteral
2.4
8.0
53
226
R71
ICD-10 Finland
Abnormality of red blood cells
10.9
7.8
14
13
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
7.0
7.8
18
26
J05AB11
ATC
valaciclovir; oral
1.7
7.8
152
952
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
7.8
136
826
M79.6
ICD-10 Finland
Pain in limb
1.5
7.7
437
3467
L04AX04
ATC
lenalidomide; oral
7.5
7.7
17
23
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
7.7
203
1372
A97
ICPC
No disease
1.6
7.6
205
1391
B01AA03
ATC
warfarin; systemic
1.6
7.6
184
1217
D07AC01
ATC
betamethasone; topical
1.5
7.6
354
2704
3AC01, ,
NOMESCO Finland
6.2
7.6
19
31
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
7.5
121
716
H02AB07
ATC
prednisone; oral
1.7
7.5
136
833
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.2
7.5
17
24
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.3
173
1136
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
7.3
50
216
D73.0
ICD-10 Finland
Hyposplenism
+∞
7.3
7
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
7.4
7.2
16
22
N03AX16
ATC
[U] pregabalin
1.5
7.2
226
1588
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
30.2
7.2
9
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
20.2
7.1
10
5
T90
ICPC
Diabetes non-insulin dependent
1.5
7.1
249
1789
153
Kela drug reimbursment
Lenalidomid
7.0
7.0
16
23
UJF30, ,
SPAT
4.4
7.0
17
39
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
7.0
139
874
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.9
263
1924
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
6.9
44
185
N06AX11
ATC
mirtazapine; oral
1.5
6.9
333
2552
XW000, ,
SPAT
40.3
6.8
8
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
6.7
86
475
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
6.6
62
306
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.6
378
2982
UJF32
NOMESCO Finland
Coloscopy
1.5
6.6
260
1913
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
3.1
6.5
26
85
B01AC04
ATC
clopidogrel; oral
1.6
6.5
169
1137
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
6.4
258
1902
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.4
257
1894
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.9
6.4
74
395
A02BC01
ATC
omeprazole; systemic
1.5
6.4
263
1949
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.4
488
4040
329
Kela drug reimbursment
Lenalidomide
8.2
6.3
13
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
6.3
186
1285
Z01.7
ICD-10 Finland
Laboratory examination
1.6
6.3
167
1126
ZXA05
NOMESCO Finland
Left side
1.5
6.3
237
1725
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
18.1
6.3
9
5
SPAT1262
SPAT
Handing over of treatment supplies
1.6
6.3
166
1120
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
6.3
6
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
6.3
6
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
6.3
6
*
H02AB04
ATC
methylprednisolone; systemic
1.6
6.2
141
915
D58.2
ICD-10 Finland
Other haemoglobinopathies
26.8
6.2
8
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.2
439
3583
J01FA10
ATC
azithromycin; systemic
1.4
6.2
525
4414
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.6
6.2
20
57
L17
ICPC
Foot/toe symptom/complaint
1.4
6.2
301
2301
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
6.2
47
214
L29
ICPC
Musculoskeletal sympt/complt other
1.8
6.2
95
556
L14
ICPC
Leg/thigh symptom/complaint
1.8
6.1
84
474
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.6
6.1
34
134
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.0
615
5318

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hematology
82 [38004501]
1.8e+00
2.6e+00
3.6e+00
1.0e+50
5.3e+00
4.9e+00
3.8e+00
cases:4.75%
controls:0.83%
cases:7.63%
controls:0.59%
cases:7.01%
controls:0.20%
cases:50.31%
controls:0.00%
cases:29.95%
controls:0.21%
cases:44.07%
controls:0.56%
cases:33.80%
controls:1.09%
46
80
923
9588
74
57
896
9617
68
19
902
9655
488
0
482
9674
289
20
676
9621
401
52
509
9283
244
83
478
7550
Monocytes/Leukocytes in Blood
26485-3 [3019069]
7.6e-01
1.9e+00
3.3e+00
6.0e+00
2.8e+00
2.2e+00
1.5e+00
cases:21.47%
controls:11.32%
cases:31.96%
controls:6.47%
cases:25.46%
controls:1.24%
cases:16.60%
controls:0.05%
cases:17.10%
controls:1.20%
cases:36.70%
controls:6.17%
cases:43.21%
controls:14.19%
208
1094
761
8574
310
626
660
9048
247
120
723
9554
161
5
809
9669
165
116
800
9525
334
576
576
8759
312
1083
410
6550
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.5e-01
1.9e+00
3.3e+00
5.9e+00
2.8e+00
2.2e+00
1.5e+00
cases:21.26%
controls:11.27%
cases:31.75%
controls:6.45%
cases:25.36%
controls:1.24%
cases:16.39%
controls:0.05%
cases:17.10%
controls:1.21%
cases:36.70%
controls:6.15%
cases:43.21%
controls:14.25%
206
1090
763
8578
308
624
662
9050
246
120
724
9554
159
5
811
9669
165
117
800
9524
334
574
576
8761
312
1088
410
6545
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.5e-01
1.9e+00
3.3e+00
5.9e+00
2.8e+00
2.2e+00
1.5e+00
cases:21.16%
controls:11.24%
cases:31.86%
controls:6.44%
cases:25.36%
controls:1.23%
cases:16.39%
controls:0.05%
cases:16.99%
controls:1.21%
cases:36.81%
controls:6.18%
cases:43.21%
controls:14.31%
205
1087
764
8581
309
623
661
9051
246
119
724
9555
159
5
811
9669
164
117
801
9524
335
577
575
8758
312
1092
410
6541
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
7.0e-01
1.9e+00
3.3e+00
5.8e+00
2.8e+00
2.2e+00
1.5e+00
cases:21.26%
controls:11.77%
cases:32.06%
controls:6.57%
cases:25.46%
controls:1.24%
cases:16.70%
controls:0.06%
cases:16.99%
controls:1.21%
cases:36.92%
controls:6.27%
cases:43.21%
controls:14.63%
206
1138
763
8530
311
636
659
9038
247
120
723
9554
162
6
808
9668
164
117
801
9524
336
585
574
8750
312
1117
410
6516
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.3e+00
2.5e+00
4.3e+00
—
4.4e+00
3.0e+00
2.5e+00
cases:7.12%
controls:1.98%
cases:12.68%
controls:1.17%
cases:13.20%
controls:0.21%
—
—
cases:10.26%
controls:0.13%
cases:21.21%
controls:1.27%
cases:24.52%
controls:2.50%
69
191
900
9477
123
113
847
9561
128
20
842
9654
—
99
13
866
9628
193
119
717
9216
177
191
545
7442
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
6.9e-01
1.9e+00
3.3e+00
5.9e+00
2.7e+00
2.2e+00
1.5e+00
cases:20.43%
controls:11.39%
cases:30.62%
controls:6.44%
cases:24.23%
controls:1.22%
cases:15.77%
controls:0.05%
cases:16.06%
controls:1.21%
cases:36.04%
controls:6.12%
cases:41.97%
controls:14.29%
198
1101
771
8567
297
623
673
9051
235
118
735
9556
153
5
817
9669
155
117
810
9524
328
571
582
8764
303
1091
419
6542
Internal Medicine
11 [38004456]
4.7e-01
1.3e+00
2.5e+00
7.1e+00
3.0e+00
2.1e+00
1.3e+00
cases:31.37%
controls:22.20%
cases:23.81%
controls:8.08%
cases:14.12%
controls:1.31%
cases:37.63%
controls:0.05%
cases:21.45%
controls:1.37%
cases:42.75%
controls:8.06%
cases:47.92%
controls:20.32%
304
2146
665
7522
231
782
739
8892
137
127
833
9547
365
5
605
9669
207
132
758
9509
389
752
521
8583
346
1551
376
6082
Eosinophils [#/volume] in Blood
26449-9 [3013115]
6.4e-01
1.8e+00
3.2e+00
5.7e+00
2.8e+00
2.1e+00
1.4e+00
cases:21.57%
controls:12.68%
cases:32.89%
controls:7.20%
cases:26.08%
controls:1.45%
cases:17.73%
controls:0.07%
cases:18.03%
controls:1.29%
cases:37.14%
controls:6.94%
cases:44.46%
controls:16.02%
209
1226
760
8442
319
697
651
8977
253
140
717
9534
172
7
798
9667
174
124
791
9517
338
648
572
8687
321
1223
401
6410
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
1.6e+00
3.0e+00
4.6e+00
1.0e+50
3.5e+00
2.8e+00
2.0e+00
cases:2.99%
controls:0.64%
cases:5.36%
controls:0.27%
cases:4.95%
controls:0.05%
cases:3.81%
controls:0.00%
cases:2.28%
controls:0.07%
cases:4.73%
controls:0.29%
cases:5.82%
controls:0.83%
29
62
940
9606
52
26
918
9648
48
5
922
9669
37
0
933
9674
22
7
943
9634
43
27
867
9308
42
63
680
7570
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
6.1e-01
1.8e+00
3.1e+00
5.7e+00
2.7e+00
2.1e+00
1.4e+00
cases:21.16%
controls:12.67%
cases:32.37%
controls:7.24%
cases:24.33%
controls:1.40%
cases:16.08%
controls:0.06%
cases:16.17%
controls:1.29%
cases:36.70%
controls:6.85%
cases:44.18%
controls:15.98%
205
1225
764
8443
314
700
656
8974
236
135
734
9539
156
6
814
9668
156
124
809
9517
334
639
576
8696
319
1220
403
6413
Monocytes [#/volume] in Blood
26484-6 [3001604]
6.5e-01
1.8e+00
3.1e+00
5.6e+00
2.7e+00
2.1e+00
1.5e+00
cases:21.05%
controls:12.22%
cases:32.16%
controls:7.04%
cases:24.33%
controls:1.40%
cases:15.98%
controls:0.07%
cases:16.17%
controls:1.24%
cases:36.48%
controls:6.70%
cases:44.04%
controls:15.49%
204
1181
765
8487
312
681
658
8993
236
135
734
9539
155
7
815
9667
156
120
809
9521
332
625
578
8710
318
1182
404
6451
Basophils [#/volume] in Blood
26444-0 [3006315]
6.5e-01
1.8e+00
3.1e+00
5.6e+00
2.7e+00
2.1e+00
1.4e+00
cases:21.05%
controls:12.26%
cases:32.27%
controls:7.05%
cases:24.33%
controls:1.40%
cases:15.98%
controls:0.07%
cases:16.17%
controls:1.26%
cases:36.48%
controls:6.75%
cases:44.04%
controls:15.67%
204
1185
765
8483
313
682
657
8992
236
135
734
9539
155
7
815
9667
156
121
809
9520
332
630
578
8705
318
1196
404
6437
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
1.5e+00
3.0e+00
4.6e+00
1.0e+50
3.6e+00
2.8e+00
1.9e+00
cases:2.99%
controls:0.67%
cases:5.36%
controls:0.27%
cases:4.95%
controls:0.05%
cases:3.81%
controls:0.00%
cases:2.49%
controls:0.07%
cases:4.73%
controls:0.31%
cases:5.82%
controls:0.90%
29
65
940
9603
52
26
918
9648
48
5
922
9669
37
0
933
9674
24
7
941
9634
43
29
867
9306
42
69
680
7564
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
1.5e+00
3.0e+00
4.6e+00
1.0e+50
3.6e+00
2.8e+00
1.9e+00
cases:2.99%
controls:0.67%
cases:5.36%
controls:0.27%
cases:4.95%
controls:0.05%
cases:3.81%
controls:0.00%
cases:2.49%
controls:0.07%
cases:4.73%
controls:0.31%
cases:5.82%
controls:0.93%
29
65
940
9603
52
26
918
9648
48
5
922
9669
37
0
933
9674
24
7
941
9634
43
29
867
9306
42
71
680
7562
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
1.5e+00
3.0e+00
4.6e+00
1.0e+50
3.6e+00
2.8e+00
1.9e+00
cases:2.99%
controls:0.67%
cases:5.36%
controls:0.27%
cases:4.95%
controls:0.05%
cases:3.81%
controls:0.00%
cases:2.49%
controls:0.07%
cases:4.73%
controls:0.31%
cases:5.82%
controls:0.93%
29
65
940
9603
52
26
918
9648
48
5
922
9669
37
0
933
9674
24
7
941
9634
43
29
867
9306
42
71
680
7562
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.0e+00
2.5e+00
4.4e+00
1.0e+50
4.6e+00
2.8e+00
1.8e+00
cases:5.78%
controls:2.11%
cases:10.00%
controls:0.93%
cases:9.48%
controls:0.13%
cases:10.52%
controls:0.00%
cases:9.33%
controls:0.10%
cases:15.05%
controls:1.04%
cases:14.96%
controls:2.71%
56
204
913
9464
97
90
873
9584
92
13
878
9661
102
0
868
9674
90
10
875
9631
137
97
773
9238
108
207
614
7426
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.1e+00
2.5e+00
4.3e+00
1.0e+50
4.7e+00
2.8e+00
1.8e+00
cases:3.72%
controls:1.30%
cases:8.14%
controls:0.73%
cases:7.42%
controls:0.11%
cases:8.97%
controls:0.00%
cases:7.46%
controls:0.07%
cases:12.64%
controls:0.90%
cases:12.47%
controls:2.21%
36
126
933
9542
79
71
891
9603
72
11
898
9663
87
0
883
9674
72
7
893
9634
115
84
795
9251
90
169
632
7464
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.9e-01
1.6e+00
2.8e+00
5.3e+00
2.6e+00
2.0e+00
1.4e+00
cases:23.63%
controls:14.62%
cases:33.20%
controls:8.77%
cases:26.70%
controls:2.13%
cases:17.84%
controls:0.11%
cases:19.69%
controls:1.88%
cases:39.67%
controls:8.28%
cases:46.26%
controls:17.52%
229
1413
740
8255
322
848
648
8826
259
206
711
9468
173
11
797
9663
190
181
775
9460
361
773
549
8562
334
1337
388
6296
Normoblasts [#/volume] in Blood
715-3 [3021589]
7.2e-01
1.5e+00
2.8e+00
5.4e+00
2.4e+00
1.7e+00
1.2e+00
cases:18.89%
controls:10.18%
cases:28.04%
controls:7.97%
cases:23.71%
controls:1.93%
cases:16.70%
controls:0.09%
cases:16.68%
controls:1.87%
cases:34.73%
controls:8.51%
cases:38.09%
controls:15.39%
183
984
786
8684
272
771
698
8903
230
187
740
9487
162
9
808
9665
161
180
804
9461
316
794
594
8541
275
1175
447
6458
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.1e+00
2.5e+00
4.4e+00
—
3.7e+00
2.4e+00
1.5e+00
cases:3.72%
controls:1.26%
cases:6.08%
controls:0.53%
cases:5.36%
controls:0.07%
—
—
cases:3.11%
controls:0.08%
cases:5.27%
controls:0.48%
cases:6.79%
controls:1.55%
36
122
933
9546
59
51
911
9623
52
7
918
9667
—
30
8
935
9633
48
45
862
9290
49
118
673
7515
Bone marrow Pathology biopsy report
33721-2 [3045142]
2.3e+00
3.8e+00
1.0e+50
1.0e+50
1.0e+50
4.7e+00
3.9e+00
cases:1.34%
controls:0.13%
cases:3.51%
controls:0.08%
cases:2.89%
controls:0.00%
cases:13.40%
controls:0.00%
cases:5.70%
controls:0.00%
cases:5.71%
controls:0.05%
cases:3.60%
controls:0.08%
13
13
956
9655
34
8
936
9666
28
0
942
9674
130
0
840
9674
55
0
910
9641
52
5
858
9330
26
6
696
7627
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
1.0e+00
2.4e+00
3.9e+00
—
3.4e+00
2.2e+00
1.4e+00
cases:4.02%
controls:1.52%
cases:6.60%
controls:0.61%
cases:5.98%
controls:0.12%
—
—
cases:3.21%
controls:0.11%
cases:5.60%
controls:0.66%
cases:7.34%
controls:2.00%
39
147
930
9521
64
59
906
9615
58
12
912
9662
—
31
11
934
9630
51
62
859
9273
53
153
669
7480
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.9e-01
9.5e-01
2.3e+00
5.5e+00
2.3e+00
1.4e+00
1.0e+00
cases:16.10%
controls:11.53%
cases:15.36%
controls:6.57%
cases:12.06%
controls:1.29%
cases:11.13%
controls:0.05%
cases:10.36%
controls:1.17%
cases:21.54%
controls:6.18%
cases:32.69%
controls:14.96%
156
1115
813
8553
149
636
821
9038
117
125
853
9549
108
5
862
9669
100
113
865
9528
196
577
714
8758
236
1142
486
6491
Differential panel, method unspecified - Blood
69738-3 [42870588]
9.1e-01
2.1e+00
3.6e+00
—
3.2e+00
2.3e+00
1.6e+00
cases:17.75%
controls:7.97%
cases:26.60%
controls:4.35%
cases:23.09%
controls:0.81%
—
—
cases:15.96%
controls:0.78%
cases:31.10%
controls:4.20%
cases:33.80%
controls:9.54%
172
771
797
8897
258
421
712
9253
224
78
746
9596
—
154
75
811
9566
283
392
627
8943
244
728
478
6905
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.2e-01
1.2e+00
2.5e+00
4.8e+00
2.3e+00
1.4e+00
9.0e-01
cases:15.58%
controls:9.87%
cases:15.26%
controls:5.04%
cases:10.00%
controls:0.90%
cases:7.01%
controls:0.06%
cases:8.19%
controls:0.87%
cases:17.69%
controls:5.14%
cases:26.32%
controls:12.71%
151
954
818
8714
148
488
822
9186
97
87
873
9587
68
6
902
9668
79
84
886
9557
161
480
749
8855
190
970
532
6663
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
1.9e+00
3.6e+00
1.0e+50
1.0e+50
—
4.4e+00
3.7e+00
cases:1.86%
controls:0.28%
cases:4.33%
controls:0.12%
cases:2.89%
controls:0.00%
cases:15.88%
controls:0.00%
—
—
cases:7.58%
controls:0.10%
cases:4.43%
controls:0.12%
18
27
951
9641
42
12
928
9662
28
0
942
9674
154
0
816
9674
—
69
9
841
9326
32
9
690
7624
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
1.6e+00
3.0e+00
—
—
3.8e+00
2.9e+00
2.1e+00
cases:2.99%
controls:0.59%
cases:5.15%
controls:0.26%
—
—
—
—
cases:2.38%
controls:0.05%
cases:4.84%
controls:0.28%
cases:5.82%
controls:0.77%
29
57
940
9611
50
25
920
9649
—
—
23
5
942
9636
44
26
866
9309
42
59
680
7574
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
7.3e-01
1.5e+00
2.7e+00
4.3e+00
2.2e+00
1.3e+00
7.2e-01
cases:16.51%
controls:8.74%
cases:20.31%
controls:5.24%
cases:9.69%
controls:0.70%
cases:3.71%
controls:0.05%
cases:5.60%
controls:0.67%
cases:16.59%
controls:5.16%
cases:24.10%
controls:13.43%
160
845
809
8823
197
507
773
9167
94
68
876
9606
36
5
934
9669
54
65
911
9576
151
482
759
8853
174
1025
548
6608
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
1.5e+00
3.3e+00
—
1.0e+50
3.8e+00
2.8e+00
2.1e+00
cases:2.89%
controls:0.64%
cases:5.36%
controls:0.22%
—
—
cases:3.61%
controls:0.00%
cases:2.28%
controls:0.05%
cases:4.40%
controls:0.28%
cases:5.54%
controls:0.75%
28
62
941
9606
52
21
918
9653
—
35
0
935
9674
22
5
943
9636
40
26
870
9309
40
57
682
7576
Essential (haemorrhagic) thrombocythaemia
D47.3 [45576400]
—
3.3e+00
—
—
1.0e+50
4.9e+00
5.2e+00
—
—
cases:1.44%
controls:0.05%
—
—
—
—
cases:4.46%
controls:0.00%
cases:10.44%
controls:0.09%
cases:13.85%
controls:0.09%
—
14
5
956
9669
—
—
43
0
922
9641
95
8
815
9327
100
7
622
7626
Bone marrow biopsy
XW000 [2001310618]
2.4e+00
3.1e+00
—
1.0e+50
—
4.6e+00
3.1e+00
cases:2.17%
controls:0.21%
cases:2.37%
controls:0.11%
—
—
cases:17.94%
controls:0.00%
—
—
cases:8.68%
controls:0.10%
cases:5.26%
controls:0.25%
21
20
948
9648
23
11
947
9663
—
174
0
796
9674
—
79
9
831
9326
38
19
684
7614
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
8.4e-01
1.8e+00
3.1e+00
—
3.9e+00
1.9e+00
1.6e+00
cases:3.20%
controls:1.41%
cases:3.92%
controls:0.68%
cases:2.47%
controls:0.11%
—
—
cases:2.90%
controls:0.06%
cases:4.51%
controls:0.73%
cases:7.06%
controls:1.45%
31
136
938
9532
38
66
932
9608
24
11
946
9663
—
28
6
937
9635
41
68
869
9267
51
111
671
7522
Polycythaemia vera
D45 [45595761]
2.0e+00
2.6e+00
—
1.0e+50
—
4.5e+00
4.0e+00
cases:0.62%
controls:0.08%
cases:1.34%
controls:0.10%
—
—
cases:0.72%
controls:0.00%
—
—
cases:7.80%
controls:0.10%
cases:8.59%
controls:0.17%
6
8
963
9660
13
10
957
9664
—
7
0
963
9674
—
71
9
839
9326
62
13
660
7620
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.4e-01
1.0e+00
2.2e+00
5.3e+00
1.9e+00
1.3e+00
8.1e-01
cases:28.48%
controls:22.02%
cases:29.18%
controls:13.16%
cases:19.48%
controls:2.51%
cases:14.74%
controls:0.08%
cases:14.72%
controls:2.42%
cases:34.40%
controls:12.91%
cases:45.15%
controls:26.77%
276
2129
693
7539
283
1273
687
8401
189
243
781
9431
143
8
827
9666
142
233
823
9408
313
1205
597
8130
326
2043
396
5590
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.1e+00
2.0e+00
3.1e+00
—
3.1e+00
2.1e+00
1.5e+00
cases:7.12%
controls:2.57%
cases:9.69%
controls:1.45%
cases:5.77%
controls:0.27%
—
—
cases:4.15%
controls:0.20%
cases:10.88%
controls:1.54%
cases:14.13%
controls:3.62%
69
248
900
9420
94
140
876
9534
56
26
914
9648
—
40
19
925
9622
99
144
811
9191
102
276
620
7357
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
1.2e+00
2.8e+00
—
—
3.9e+00
2.9e+00
1.8e+00
cases:1.96%
controls:0.59%
cases:4.43%
controls:0.27%
—
—
—
—
cases:2.49%
controls:0.05%
cases:4.95%
controls:0.29%
cases:4.57%
controls:0.76%
19
57
950
9611
43
26
927
9648
—
—
24
5
941
9636
45
27
865
9308
33
58
689
7575
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
1.2e+00
2.8e+00
—
—
3.9e+00
2.9e+00
1.8e+00
cases:1.96%
controls:0.60%
cases:4.33%
controls:0.27%
—
—
—
—
cases:2.49%
controls:0.05%
cases:4.95%
controls:0.29%
cases:4.57%
controls:0.76%
19
58
950
9610
42
26
928
9648
—
—
24
5
941
9636
45
27
865
9308
33
58
689
7575
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
1.2e+00
2.8e+00
—
—
3.8e+00
2.9e+00
1.9e+00
cases:1.86%
controls:0.58%
cases:4.23%
controls:0.26%
—
—
—
—
cases:2.18%
controls:0.05%
cases:4.84%
controls:0.29%
cases:4.57%
controls:0.68%
18
56
951
9612
41
25
929
9649
—
—
21
5
944
9636
44
27
866
9308
33
52
689
7581
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.1e+00
2.0e+00
3.0e+00
—
2.9e+00
2.0e+00
1.4e+00
cases:7.33%
controls:2.67%
cases:10.21%
controls:1.53%
cases:5.57%
controls:0.29%
—
—
cases:3.94%
controls:0.23%
cases:10.99%
controls:1.63%
cases:13.85%
controls:3.94%
71
258
898
9410
99
148
871
9526
54
28
916
9646
—
38
22
927
9619
100
152
810
9183
100
301
622
7332
Anaemia, unspecified
D64.9 [45600610]
4.2e-01
2.0e+00
3.8e+00
—
3.3e+00
2.1e+00
1.0e+00
cases:1.75%
controls:1.16%
cases:3.92%
controls:0.55%
cases:2.78%
controls:0.06%
—
—
cases:2.38%
controls:0.09%
cases:4.07%
controls:0.50%
cases:4.16%
controls:1.57%
17
112
952
9556
38
53
932
9621
27
6
943
9668
—
23
9
942
9632
37
47
873
9288
30
120
692
7513
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
9.8e-01
2.0e+00
3.0e+00
—
2.9e+00
1.9e+00
1.3e+00
cases:7.33%
controls:2.88%
cases:10.41%
controls:1.61%
cases:5.67%
controls:0.30%
—
—
cases:3.94%
controls:0.22%
cases:10.99%
controls:1.80%
cases:14.27%
controls:4.47%
71
278
898
9390
101
156
869
9518
55
29
915
9645
—
38
21
927
9620
100
168
810
9167
103
341
619
7292
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.2e+00
1.9e+00
2.5e+00
—
3.3e+00
2.5e+00
1.7e+00
cases:0.93%
controls:0.28%
cases:1.75%
controls:0.26%
cases:0.62%
controls:0.05%
—
—
cases:1.45%
controls:0.05%
cases:2.64%
controls:0.21%
cases:2.49%
controls:0.46%
9
27
960
9641
17
25
953
9649
6
5
964
9669
—
14
5
951
9636
24
20
886
9315
18
35
704
7598
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
9.9e-01
1.5e+00
2.8e+00
1.0e+50
3.1e+00
1.7e+00
1.4e+00
cases:14.55%
controls:5.94%
cases:10.93%
controls:2.70%
cases:5.88%
controls:0.36%
cases:4.23%
controls:0.00%
cases:5.39%
controls:0.25%
cases:11.54%
controls:2.43%
cases:21.47%
controls:6.16%
141
574
828
9094
106
261
864
9413
57
35
913
9639
41
0
929
9674
52
24
913
9617
105
227
805
9108
155
470
567
7163
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
8.0e-01
1.6e+00
2.8e+00
—
3.2e+00
1.7e+00
1.5e+00
cases:4.85%
controls:2.24%
cases:4.12%
controls:0.89%
cases:1.96%
controls:0.12%
—
—
cases:1.97%
controls:0.08%
cases:4.18%
controls:0.82%
cases:9.56%
controls:2.37%
47
217
922
9451
40
86
930
9588
19
12
951
9662
—
19
8
946
9633
38
77
872
9258
69
181
653
7452
Abdominal ultrasound examination
JN3AE [2001305555]
8.7e-01
1.5e+00
2.6e+00
1.0e+50
3.0e+00
2.1e+00
1.3e+00
cases:3.92%
controls:1.68%
cases:2.27%
controls:0.51%
cases:0.93%
controls:0.07%
cases:3.71%
controls:0.00%
cases:1.87%
controls:0.09%
cases:3.19%
controls:0.41%
cases:4.85%
controls:1.40%
38
162
931
9506
22
49
948
9625
9
7
961
9667
36
0
934
9674
18
9
947
9632
29
38
881
9297
35
107
687
7526
Outpatient Visit
OP [9202]
3.0e-01
6.0e-01
9.4e-01
5.4e+00
1.6e+00
1.3e+00
9.8e-01
cases:79.46%
controls:74.08%
cases:66.49%
controls:52.19%
cases:22.78%
controls:10.38%
cases:49.07%
controls:0.42%
cases:37.72%
controls:10.50%
cases:79.78%
controls:51.17%
cases:90.17%
controls:77.43%
770
7162
199
2506
645
5049
325
4625
221
1004
749
8670
476
41
494
9633
364
1012
601
8629
726
4777
184
4558
651
5910
71
1723
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.7e-01
8.3e-01
2.1e+00
4.6e+00
1.7e+00
1.0e+00
5.7e-01
cases:34.98%
controls:27.11%
cases:38.14%
controls:21.22%
cases:30.00%
controls:4.98%
cases:19.69%
controls:0.24%
cases:22.69%
controls:5.14%
cases:43.85%
controls:22.29%
cases:50.97%
controls:37.00%
339
2621
630
7047
370
2053
600
7621
291
482
679
9192
191
23
779
9651
219
496
746
9145
399
2081
511
7254
368
2824
354
4809
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.6e-01
8.7e-01
2.0e+00
4.4e+00
1.7e+00
9.2e-01
5.2e-01
cases:38.08%
controls:32.21%
cases:37.42%
controls:19.97%
cases:22.89%
controls:3.88%
cases:15.26%
controls:0.23%
cases:18.86%
controls:4.17%
cases:39.23%
controls:20.44%
cases:53.32%
controls:40.50%
369
3114
600
6554
363
1932
607
7742
222
375
748
9299
148
22
822
9652
182
402
783
9239
357
1908
553
7427
385
3091
337
4542
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
1.8e+00
3.4e+00
—
1.0e+50
—
3.0e+00
2.4e+00
cases:2.89%
controls:0.50%
cases:4.85%
controls:0.18%
—
—
cases:3.40%
controls:0.00%
—
—
cases:4.29%
controls:0.21%
cases:5.54%
controls:0.54%
28
48
941
9620
47
17
923
9657
—
33
0
937
9674
—
39
20
871
9315
40
41
682
7592
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15061-5 [3024172]
1.4e+00
4.0e+00
1.0e+50
1.0e+50
1.0e+50
4.0e+00
2.5e+00
cases:0.93%
controls:0.24%
cases:6.91%
controls:0.13%
cases:6.49%
controls:0.00%
cases:2.47%
controls:0.00%
cases:2.28%
controls:0.00%
cases:5.49%
controls:0.11%
cases:3.88%
controls:0.31%
9
23
960
9645
67
13
903
9661
63
0
907
9674
24
0
946
9674
22
0
943
9641
50
10
860
9325
28
24
694
7609
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
1.7e+00
3.4e+00
—
1.0e+50
—
3.1e+00
2.3e+00
cases:2.79%
controls:0.50%
cases:4.85%
controls:0.18%
—
—
cases:3.40%
controls:0.00%
—
—
cases:4.18%
controls:0.20%
cases:5.12%
controls:0.52%
27
48
942
9620
47
17
923
9657
—
33
0
937
9674
—
38
19
872
9316
37
40
685
7593
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
3.5e-01
1.2e+00
3.3e+00
1.0e+50
3.5e+00
1.5e+00
1.0e+00
cases:4.54%
controls:3.24%
cases:3.71%
controls:1.20%
cases:2.16%
controls:0.08%
cases:1.55%
controls:0.00%
cases:3.42%
controls:0.10%
cases:4.18%
controls:0.97%
cases:8.59%
controls:3.21%
44
313
925
9355
36
116
934
9558
21
8
949
9666
15
0
955
9674
33
10
932
9631
38
91
872
9244
62
245
660
7388
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
1.8e+00
3.3e+00
—
1.0e+50
—
3.0e+00
2.4e+00
cases:2.99%
controls:0.52%
cases:4.95%
controls:0.19%
—
—
cases:3.61%
controls:0.00%
—
—
cases:4.40%
controls:0.24%
cases:5.82%
controls:0.55%
29
50
940
9618
48
18
922
9656
—
35
0
935
9674
—
40
22
870
9313
42
42
680
7591
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
1.4e+00
—
—
—
1.0e+50
5.6e+00
3.4e+00
cases:1.03%
controls:0.25%
—
—
—
—
—
—
cases:6.53%
controls:0.00%
cases:12.64%
controls:0.05%
cases:7.62%
controls:0.26%
10
24
959
9644
—
—
—
63
0
902
9641
115
5
795
9330
55
20
667
7613
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
8.8e-01
2.1e+00
3.5e+00
—
—
2.2e+00
1.7e+00
cases:2.48%
controls:1.04%
cases:3.30%
controls:0.41%
cases:1.75%
controls:0.05%
—
—
—
—
cases:3.52%
controls:0.42%
cases:5.26%
controls:0.97%
24
101
945
9567
32
40
938
9634
17
5
953
9669
—
—
32
39
878
9296
38
74
684
7559
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
4.2e-01
1.2e+00
2.9e+00
1.0e+50
3.9e+00
1.3e+00
7.4e-01
cases:5.26%
controls:3.51%
cases:4.33%
controls:1.34%
cases:2.99%
controls:0.17%
cases:3.20%
controls:0.00%
cases:3.42%
controls:0.07%
cases:4.84%
controls:1.33%
cases:7.34%
controls:3.66%
51
339
918
9329
42
130
928
9544
29
16
941
9658
31
0
939
9674
33
7
932
9634
44
124
866
9211
53
279
669
7354
JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
80187-8 [21494670]
2.1e+00
4.8e+00
—
1.0e+50
1.0e+50
3.0e+00
1.7e+00
cases:1.34%
controls:0.17%
cases:8.25%
controls:0.07%
—
—
cases:2.58%
controls:0.00%
cases:1.55%
controls:0.00%
cases:1.32%
controls:0.06%
cases:0.69%
controls:0.13%
13
16
956
9652
80
7
890
9667
—
25
0
945
9674
15
0
950
9641
12
6
898
9329
5
10
717
7623
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
7.9e-01
1.3e+00
2.3e+00
—
3.1e+00
1.6e+00
9.0e-01
cases:2.37%
controls:1.09%
cases:1.86%
controls:0.54%
cases:0.82%
controls:0.08%
—
—
cases:1.14%
controls:0.05%
cases:2.42%
controls:0.50%
cases:4.02%
controls:1.68%
23
105
946
9563
18
52
952
9622
8
8
962
9666
—
11
5
954
9636
22
47
888
9288
29
128
693
7505
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
8.2e-01
1.5e+00
2.8e+00
—
2.5e+00
1.3e+00
9.2e-01
cases:3.41%
controls:1.53%
cases:2.99%
controls:0.66%
cases:1.44%
controls:0.09%
—
—
cases:0.62%
controls:0.05%
cases:2.31%
controls:0.61%
cases:4.43%
controls:1.81%
33
148
936
9520
29
64
941
9610
14
9
956
9665
—
6
5
959
9636
21
57
889
9278
32
138
690
7495
Microorganisms panel - Urine sediment
58435-9 [40761536]
7.1e-01
1.3e+00
2.4e+00
—
2.4e+00
1.6e+00
1.4e+00
cases:4.13%
controls:2.07%
cases:3.09%
controls:0.87%
cases:1.75%
controls:0.16%
—
—
cases:0.93%
controls:0.08%
cases:3.19%
controls:0.65%
cases:6.93%
controls:1.85%
40
200
929
9468
30
84
940
9590
17
15
953
9659
—
9
8
956
9633
29
61
881
9274
50
141
672
7492
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.3e-01
6.8e-01
1.8e+00
4.3e+00
1.4e+00
7.8e-01
4.7e-01
cases:35.09%
controls:28.03%
cases:37.53%
controls:23.28%
cases:24.23%
controls:5.15%
cases:14.85%
controls:0.24%
cases:17.93%
controls:5.14%
cases:40.22%
controls:23.56%
cases:50.55%
controls:39.07%
340
2710
629
6958
364
2252
606
7422
235
498
735
9176
144
23
826
9651
173
496
792
9145
366
2199
544
7136
365
2982
357
4651
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
7.9e-01
1.7e+00
2.5e+00
—
2.5e+00
1.3e+00
8.1e-01
cases:10.53%
controls:5.08%
cases:12.16%
controls:2.41%
cases:4.12%
controls:0.36%
—
—
cases:3.63%
controls:0.30%
cases:7.80%
controls:2.36%
cases:14.82%
controls:7.18%
102
491
867
9177
118
233
852
9441
40
35
930
9639
—
35
29
930
9612
71
220
839
9115
107
548
615
7085
hydroxycarbamide; oral
L01XX05 [21603787]
1.8e+00
1.5e+00
—
—
—
4.7e+00
4.8e+00
cases:0.52%
controls:0.08%
cases:0.52%
controls:0.11%
—
—
—
—
—
—
cases:9.89%
controls:0.10%
cases:14.96%
controls:0.14%
5
8
964
9660
5
11
965
9663
—
—
—
90
9
820
9326
108
11
614
7622
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.7e-01
6.0e-01
1.8e+00
4.7e+00
1.4e+00
7.3e-01
3.5e-01
cases:41.28%
controls:37.32%
cases:41.55%
controls:28.12%
cases:24.54%
controls:5.29%
cases:15.15%
controls:0.17%
cases:17.51%
controls:4.91%
cases:44.73%
controls:28.02%
cases:57.89%
controls:49.22%
400
3608
569
6060
403
2720
567
6954
238
512
732
9162
147
16
823
9658
169
473
796
9168
407
2616
503
6719
418
3757
304
3876
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
3.6e-01
1.2e+00
2.9e+00
1.0e+50
2.7e+00
1.6e+00
1.1e+00
cases:9.18%
controls:6.60%
cases:8.04%
controls:2.67%
cases:5.88%
controls:0.35%
cases:6.80%
controls:0.00%
cases:6.11%
controls:0.41%
cases:11.43%
controls:2.59%
cases:17.87%
controls:6.77%
89
638
880
9030
78
258
892
9416
57
34
913
9640
66
0
904
9674
59
40
906
9601
104
242
806
9093
129
517
593
7116
Short blood count panel - Blood
55429-5 [40758558]
8.4e-01
1.3e+00
2.5e+00
—
2.1e+00
1.4e+00
1.2e+00
cases:13.00%
controls:6.08%
cases:10.31%
controls:3.17%
cases:7.84%
controls:0.71%
—
—
cases:5.80%
controls:0.72%
cases:11.43%
controls:2.96%
cases:20.78%
controls:7.01%
126
588
843
9080
100
307
870
9367
76
69
894
9605
—
56
69
909
9572
104
276
806
9059
150
535
572
7098
Medical doctor
Z2221 [2001311556]
9.1e-01
1.2e+00
1.6e+00
1.0e+50
2.6e+00
1.8e+00
1.3e+00
cases:10.53%
controls:4.52%
cases:4.02%
controls:1.29%
cases:1.03%
controls:0.22%
cases:7.84%
controls:0.00%
cases:1.97%
controls:0.15%
cases:6.48%
controls:1.14%
cases:10.11%
controls:2.93%
102
437
867
9231
39
125
931
9549
10
21
960
9653
76
0
894
9674
19
14
946
9627
59
106
851
9229
73
224
649
7409
12 lead EKG panel
34534-8 [3044889]
3.4e-01
7.4e-01
1.6e+00
4.2e+00
1.3e+00
6.2e-01
5.0e-01
cases:26.93%
controls:20.75%
cases:19.59%
controls:10.41%
cases:6.08%
controls:1.32%
cases:3.51%
controls:0.05%
cases:4.25%
controls:1.14%
cases:17.03%
controls:9.97%
cases:35.18%
controls:24.84%
261
2006
708
7662
190
1007
780
8667
59
128
911
9546
34
5
936
9669
41
110
924
9531
155
931
755
8404
254
1896
468
5737
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.1e+00
1.2e+00
2.2e+00
1.0e+50
2.0e+00
1.5e+00
1.3e+00
cases:2.79%
controls:0.92%
cases:1.86%
controls:0.58%
cases:1.24%
controls:0.13%
cases:0.52%
controls:0.00%
cases:0.83%
controls:0.11%
cases:2.97%
controls:0.67%
cases:5.26%
controls:1.44%
27
89
942
9579
18
56
952
9618
12
13
958
9661
5
0
965
9674
8
11
957
9630
27
63
883
9272
38
110
684
7523
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
3.8e-01
1.2e+00
3.3e+00
1.0e+50
3.1e+00
1.2e+00
6.8e-01
cases:5.99%
controls:4.19%
cases:4.64%
controls:1.51%
cases:2.37%
controls:0.09%
cases:1.75%
controls:0.00%
cases:3.01%
controls:0.15%
cases:4.29%
controls:1.37%
cases:9.42%
controls:5.02%
58
405
911
9263
45
146
925
9528
23
9
947
9665
17
0
953
9674
29
14
936
9627
39
128
871
9207
68
383
654
7250
Infectious Disease
44 [38004484]
7.0e-01
1.2e+00
2.3e+00
—
2.5e+00
1.8e+00
7.6e-01
cases:3.72%
controls:1.87%
cases:2.06%
controls:0.65%
cases:1.24%
controls:0.12%
—
—
cases:1.35%
controls:0.11%
cases:3.74%
controls:0.61%
cases:3.74%
controls:1.78%
36
181
933
9487
20
63
950
9611
12
12
958
9662
—
13
11
952
9630
34
57
876
9278
27
136
695
7497
pH of Serum or Plasma
2753-2 [3018418]
7.5e-01
1.2e+00
2.3e+00
—
2.2e+00
1.5e+00
1.1e+00
cases:13.52%
controls:6.85%
cases:11.65%
controls:3.70%
cases:6.49%
controls:0.66%
—
—
cases:5.08%
controls:0.58%
cases:14.40%
controls:3.51%
cases:22.99%
controls:8.83%
131
662
838
9006
113
358
857
9316
63
64
907
9610
—
49
56
916
9585
131
328
779
9007
166
674
556
6959
Gas panel - Venous blood
24339-4 [3000991]
8.7e-01
1.2e+00
2.5e+00
—
2.2e+00
1.3e+00
1.0e+00
cases:3.72%
controls:1.59%
cases:2.78%
controls:0.87%
cases:1.55%
controls:0.12%
—
—
cases:1.04%
controls:0.11%
cases:3.74%
controls:1.00%
cases:6.23%
controls:2.28%
36
154
933
9514
27
84
943
9590
15
12
955
9662
—
10
11
955
9630
34
93
876
9242
45
174
677
7459
Immunofixation for Serum or Plasma
25700-6 [3037756]
1.2e+00
3.0e+00
—
—
—
3.2e+00
1.8e+00
cases:1.24%
controls:0.36%
cases:3.30%
controls:0.18%
—
—
—
—
—
—
cases:1.87%
controls:0.07%
cases:1.80%
controls:0.31%
12
35
957
9633
32
17
938
9657
—
—
—
17
7
893
9328
13
24
709
7609
Oncology Clinic/Center
261QX0200X [38004268]
3.2e-01
5.2e-01
3.1e+00
1.0e+50
3.9e+00
1.5e+00
4.9e-01
cases:8.57%
controls:6.39%
cases:2.78%
controls:1.67%
cases:3.09%
controls:0.14%
cases:8.04%
controls:0.00%
cases:8.70%
controls:0.19%
cases:6.26%
controls:1.45%
cases:8.03%
controls:5.07%
83
618
886
9050
27
162
943
9512
30
14
940
9660
78
0
892
9674
84
18
881
9623
57
135
853
9200
58
387
664
7246
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
9.6e-01
2.3e+00
2.8e+00
1.0e+50
—
1.9e+00
2.0e+00
cases:1.34%
controls:0.52%
cases:2.68%
controls:0.28%
cases:0.82%
controls:0.05%
cases:1.24%
controls:0.00%
—
—
cases:2.42%
controls:0.36%
cases:5.82%
controls:0.80%
13
50
956
9618
26
27
944
9647
8
5
962
9669
12
0
958
9674
—
22
34
888
9301
42
61
680
7572
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.6e+00
2.8e+00
—
1.0e+50
—
2.5e+00
2.0e+00
cases:3.92%
controls:0.81%
cases:5.15%
controls:0.32%
—
—
cases:0.72%
controls:0.00%
—
—
cases:4.29%
controls:0.35%
cases:5.96%
controls:0.86%
38
78
931
9590
50
31
920
9643
—
7
0
963
9674
—
39
33
871
9302
43
66
679
7567
Platelets [#/volume] in Blood
26515-7 [3007461]
1.2e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.8e-01
2.3e-01
cases:44.99%
controls:42.15%
cases:48.04%
controls:34.50%
cases:35.98%
controls:7.85%
cases:23.51%
controls:0.39%
cases:27.77%
controls:8.12%
cases:51.54%
controls:34.95%
cases:59.97%
controls:54.38%
436
4075
533
5593
466
3338
504
6336
349
759
621
8915
228
38
742
9636
268
783
697
8858
469
3263
441
6072
433
4151
289
3482
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.7e-01
2.2e-01
cases:45.10%
controls:42.21%
cases:48.14%
controls:34.56%
cases:35.98%
controls:7.88%
cases:23.51%
controls:0.39%
cases:27.77%
controls:8.10%
cases:51.43%
controls:35.04%
cases:59.97%
controls:54.54%
437
4081
532
5587
467
3343
503
6331
349
762
621
8912
228
38
742
9636
268
781
697
8860
468
3271
442
6064
433
4163
289
3470
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.2e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.8e-01
2.2e-01
cases:45.10%
controls:42.22%
cases:47.94%
controls:34.53%
cases:36.08%
controls:7.90%
cases:23.61%
controls:0.39%
cases:27.67%
controls:8.11%
cases:51.43%
controls:35.02%
cases:59.97%
controls:54.54%
437
4082
532
5586
465
3340
505
6334
350
764
620
8910
229
38
741
9636
267
782
698
8859
468
3269
442
6066
433
4163
289
3470
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.7e-01
2.2e-01
cases:45.10%
controls:42.22%
cases:48.14%
controls:34.56%
cases:35.98%
controls:7.90%
cases:23.51%
controls:0.39%
cases:27.77%
controls:8.11%
cases:51.43%
controls:35.06%
cases:59.97%
controls:54.58%
437
4082
532
5586
467
3343
503
6331
349
764
621
8910
228
38
742
9636
268
782
697
8859
468
3273
442
6062
433
4166
289
3467
MCH [Entitic mass]
28539-5 [3035941]
1.1e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.8e-01
2.2e-01
cases:44.99%
controls:42.19%
cases:47.84%
controls:34.47%
cases:35.98%
controls:7.87%
cases:23.51%
controls:0.39%
cases:27.67%
controls:8.11%
cases:51.43%
controls:35.00%
cases:59.97%
controls:54.50%
436
4079
533
5589
464
3335
506
6339
349
761
621
8913
228
38
742
9636
267
782
698
8859
468
3267
442
6068
433
4160
289
3473
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.2e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.7e-01
2.2e-01
cases:45.10%
controls:42.23%
cases:48.14%
controls:34.56%
cases:35.98%
controls:7.91%
cases:23.51%
controls:0.39%
cases:27.77%
controls:8.16%
cases:51.43%
controls:35.16%
cases:59.97%
controls:54.63%
437
4083
532
5585
467
3343
503
6331
349
765
621
8909
228
38
742
9636
268
787
697
8854
468
3282
442
6053
433
4170
289
3463
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.1e-01
5.6e-01
1.9e+00
4.4e+00
1.5e+00
6.8e-01
2.2e-01
cases:44.99%
controls:42.25%
cases:47.94%
controls:34.52%
cases:35.98%
controls:7.93%
cases:23.51%
controls:0.39%
cases:27.67%
controls:8.14%
cases:51.54%
controls:35.13%
cases:59.97%
controls:54.58%
436
4085
533
5583
465
3339
505
6335
349
767
621
8907
228
38
742
9636
267
785
698
8856
469
3279
441
6056
433
4166
289
3467
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
5.3e-01
1.4e+00
2.7e+00
—
2.6e+00
1.1e+00
5.7e-01
cases:6.19%
controls:3.73%
cases:9.28%
controls:2.36%
cases:3.61%
controls:0.26%
—
—
cases:2.90%
controls:0.22%
cases:6.48%
controls:2.30%
cases:14.13%
controls:8.52%
60
361
909
9307
90
228
880
9446
35
25
935
9649
—
28
21
937
9620
59
215
851
9120
102
650
620
6983
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.5e-01
9.8e-01
2.0e+00
—
2.5e+00
1.6e+00
1.2e+00
cases:5.16%
controls:2.75%
cases:4.23%
controls:1.62%
cases:2.68%
controls:0.37%
—
—
cases:3.52%
controls:0.31%
cases:7.69%
controls:1.64%
cases:9.70%
controls:3.13%
50
266
919
9402
41
157
929
9517
26
36
944
9638
—
34
30
931
9611
70
153
840
9182
70
239
652
7394
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.0e-01
5.7e-01
1.9e+00
4.3e+00
1.5e+00
6.3e-01
2.3e-01
cases:33.44%
controls:31.18%
cases:34.95%
controls:23.36%
cases:26.29%
controls:5.05%
cases:16.80%
controls:0.28%
cases:20.10%
controls:5.26%
cases:36.48%
controls:23.35%
cases:45.57%
controls:39.88%
324
3014
645
6654
339
2260
631
7414
255
489
715
9185
163
27
807
9647
194
507
771
9134
332
2180
578
7155
329
3044
393
4589
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.3e-01
7.1e-01
1.7e+00
3.8e+00
1.5e+00
6.7e-01
4.7e-01
cases:21.47%
controls:19.28%
cases:17.01%
controls:9.17%
cases:6.60%
controls:1.26%
cases:3.20%
controls:0.07%
cases:5.49%
controls:1.27%
cases:16.37%
controls:9.12%
cases:30.75%
controls:21.72%
208
1864
761
7804
165
887
805
8787
64
122
906
9552
31
7
939
9667
53
122
912
9519
149
851
761
8484
222
1658
500
5975
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
55774-4 [40758895]
—
3.0e+00
1.0e+50
1.0e+50
1.0e+50
3.1e+00
2.7e+00
—
—
cases:1.03%
controls:0.05%
cases:1.24%
controls:0.00%
cases:0.93%
controls:0.00%
cases:0.83%
controls:0.00%
cases:1.43%
controls:0.06%
cases:1.52%
controls:0.10%
—
10
5
960
9669
12
0
958
9674
9
0
961
9674
8
0
957
9641
13
6
897
9329
11
8
711
7625
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
55776-9 [40758897]
—
3.0e+00
1.0e+50
1.0e+50
1.0e+50
3.1e+00
2.7e+00
—
—
cases:1.03%
controls:0.05%
cases:1.24%
controls:0.00%
cases:0.93%
controls:0.00%
cases:0.83%
controls:0.00%
cases:1.43%
controls:0.06%
cases:1.52%
controls:0.10%
—
10
5
960
9669
12
0
958
9674
9
0
961
9674
8
0
957
9641
13
6
897
9329
11
8
711
7625
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
7.1e-01
1.3e+00
2.4e+00
—
2.2e+00
1.3e+00
8.5e-01
cases:6.40%
controls:3.26%
cases:6.19%
controls:1.71%
cases:2.68%
controls:0.25%
—
—
cases:2.38%
controls:0.27%
cases:6.26%
controls:1.84%
cases:10.25%
controls:4.66%
62
315
907
9353
60
165
910
9509
26
24
944
9650
—
23
26
942
9615
57
172
853
9163
74
356
648
7277
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
6.9e-01
1.4e+00
2.4e+00
—
2.2e+00
1.4e+00
1.4e+00
cases:2.06%
controls:1.04%
cases:3.61%
controls:0.95%
cases:1.96%
controls:0.19%
—
—
cases:1.87%
controls:0.21%
cases:4.51%
controls:1.10%
cases:9.14%
controls:2.52%
20
101
949
9567
35
92
935
9582
19
18
951
9656
—
18
20
947
9621
41
103
869
9232
66
192
656
7441
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.7e-01
5.4e-01
1.7e+00
4.3e+00
1.3e+00
6.1e-01
3.0e-01
cases:43.34%
controls:39.29%
cases:44.85%
controls:32.17%
cases:29.07%
controls:7.11%
cases:18.14%
controls:0.31%
cases:22.18%
controls:7.01%
cases:46.70%
controls:32.20%
cases:58.73%
controls:51.37%
420
3799
549
5869
435
3112
535
6562
282
688
688
8986
176
30
794
9644
214
676
751
8965
425
3006
485
6329
424
3921
298
3712
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.8e-01
5.5e-01
1.6e+00
4.2e+00
1.4e+00
5.9e-01
3.3e-01
cases:40.76%
controls:36.44%
cases:40.41%
controls:28.14%
cases:23.30%
controls:5.54%
cases:15.67%
controls:0.29%
cases:19.59%
controls:5.82%
cases:41.76%
controls:28.39%
cases:56.09%
controls:47.79%
395
3523
574
6145
392
2722
578
6952
226
536
744
9138
152
28
818
9646
189
561
776
9080
380
2650
530
6685
405
3648
317
3985
Multiple myeloma
C90.0 [45600562]
-1.0e+50
—
—
—
3.2e+00
2.9e+00
2.5e+00
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:1.97%
controls:0.08%
cases:2.86%
controls:0.16%
cases:2.22%
controls:0.18%
0
10
969
9658
—
—
—
19
8
946
9633
26
15
884
9320
16
14
706
7619
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
7.6e-01
1.2e+00
2.4e+00
—
2.2e+00
1.5e+00
1.3e+00
cases:2.37%
controls:1.13%
cases:3.40%
controls:1.06%
cases:2.27%
controls:0.21%
—
—
cases:1.97%
controls:0.22%
cases:5.05%
controls:1.17%
cases:8.86%
controls:2.65%
23
109
946
9559
33
103
937
9571
22
20
948
9654
—
19
21
946
9620
46
109
864
9226
64
202
658
7431
Bacteria [Presence] in Urine
87829-8 [36304419]
6.9e-01
1.3e+00
2.4e+00
—
2.1e+00
1.2e+00
8.9e-01
cases:11.66%
controls:6.22%
cases:9.59%
controls:2.84%
cases:4.12%
controls:0.38%
—
—
cases:3.11%
controls:0.39%
cases:9.01%
controls:2.91%
cases:16.90%
controls:7.72%
113
601
856
9067
93
275
877
9399
40
37
930
9637
—
30
38
935
9603
82
272
828
9063
122
589
600
7044
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.9e-01
9.6e-01
2.2e+00
1.0e+50
2.7e+00
1.3e+00
9.0e-01
cases:7.33%
controls:4.62%
cases:5.05%
controls:2.01%
cases:2.78%
controls:0.31%
cases:0.93%
controls:0.00%
cases:3.73%
controls:0.27%
cases:6.70%
controls:1.92%
cases:12.19%
controls:5.36%
71
447
898
9221
49
194
921
9480
27
30
943
9644
9
0
961
9674
36
26
929
9615
61
179
849
9156
88
409
634
7224
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
7.1e-01
1.2e+00
2.5e+00
—
2.0e+00
1.5e+00
1.3e+00
cases:2.17%
controls:1.08%
cases:3.40%
controls:1.03%
cases:2.27%
controls:0.20%
—
—
cases:1.66%
controls:0.22%
cases:4.62%
controls:1.10%
cases:8.86%
controls:2.54%
21
104
948
9564
33
100
937
9574
22
19
948
9655
—
16
21
949
9620
42
103
868
9232
64
194
658
7439
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
3.6e-01
1.5e+00
2.6e+00
—
2.2e+00
1.3e+00
8.5e-01
cases:6.50%
controls:4.64%
cases:10.41%
controls:2.65%
cases:6.49%
controls:0.50%
—
—
cases:4.04%
controls:0.45%
cases:9.01%
controls:2.68%
cases:13.71%
controls:6.37%
63
449
906
9219
101
256
869
9418
63
48
907
9626
—
39
43
926
9598
82
250
828
9085
99
486
623
7147
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
8.3e-01
1.2e+00
2.1e+00
—
2.6e+00
1.1e+00
7.6e-01
cases:3.20%
controls:1.43%
cases:2.27%
controls:0.72%
cases:0.72%
controls:0.09%
—
—
cases:0.93%
controls:0.07%
cases:2.64%
controls:0.92%
cases:4.99%
controls:2.40%
31
138
938
9530
22
70
948
9604
7
9
963
9665
—
9
7
956
9634
24
86
886
9249
36
183
686
7450
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.8e-01
5.5e-01
1.6e+00
4.1e+00
1.3e+00
5.4e-01
3.1e-01
cases:40.56%
controls:36.25%
cases:39.90%
controls:27.77%
cases:22.37%
controls:5.42%
cases:15.05%
controls:0.30%
cases:18.24%
controls:5.67%
cases:40.33%
controls:28.16%
cases:55.40%
controls:47.60%
393
3505
576
6163
387
2686
583
6988
217
524
753
9150
146
29
824
9645
176
547
789
9094
367
2629
543
6706
400
3633
322
4000
Essential (primary) hypertension
I10 [45591453]
2.1e-01
5.1e-01
1.2e+00
4.6e+00
1.4e+00
6.8e-01
2.8e-01
cases:22.70%
controls:19.24%
cases:15.67%
controls:10.03%
cases:5.57%
controls:1.78%
cases:8.25%
controls:0.09%
cases:7.36%
controls:1.84%
cases:18.57%
controls:10.32%
cases:29.78%
controls:24.24%
220
1860
749
7808
152
970
818
8704
54
172
916
9502
80
9
890
9665
71
177
894
9464
169
963
741
8372
215
1850
507
5783
Thrombocytopenia, unspecified
D69.6 [45581327]
2.0e+00
3.4e+00
1.0e+50
1.0e+50
—
3.0e+00
—
cases:0.62%
controls:0.08%
cases:1.55%
controls:0.05%
cases:0.93%
controls:0.00%
cases:0.52%
controls:0.00%
—
—
cases:1.43%
controls:0.07%
—
—
6
8
963
9660
15
5
955
9669
9
0
961
9674
5
0
965
9674
—
13
7
897
9328
—
Blasts/Leukocytes in Blood
26446-5 [3025159]
8.1e-01
1.3e+00
2.4e+00
—
2.1e+00
1.4e+00
1.3e+00
cases:2.17%
controls:0.97%
cases:3.40%
controls:0.99%
cases:2.37%
controls:0.23%
—
—
cases:1.76%
controls:0.22%
cases:4.40%
controls:1.16%
cases:9.00%
controls:2.65%
21
94
948
9574
33
96
937
9578
23
22
947
9652
—
17
21
948
9620
40
108
870
9227
65
202
657
7431
Physiotherapy
R4110 [2001310233]
8.5e-01
9.6e-01
2.2e+00
1.0e+50
1.6e+00
1.6e+00
1.1e+00
cases:11.76%
controls:5.39%
cases:4.43%
controls:1.74%
cases:2.06%
controls:0.23%
cases:0.62%
controls:0.00%
cases:1.35%
controls:0.28%
cases:7.03%
controls:1.53%
cases:11.91%
controls:4.48%
114
521
855
9147
43
168
927
9506
20
22
950
9652
6
0
964
9674
13
27
952
9614
64
143
846
9192
86
342
636
7291
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.3e-01
8.7e-01
1.9e+00
1.0e+50
2.8e+00
1.3e+00
8.7e-01
cases:10.01%
controls:6.73%
cases:6.08%
controls:2.65%
cases:2.68%
controls:0.40%
cases:1.13%
controls:0.00%
cases:4.35%
controls:0.27%
cases:8.02%
controls:2.31%
cases:15.24%
controls:7.01%
97
651
872
9017
59
256
911
9418
26
39
944
9635
11
0
959
9674
42
26
923
9615
73
216
837
9119
110
535
612
7098
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
7.0e-01
1.3e+00
2.3e+00
—
2.0e+00
1.2e+00
7.5e-01
cases:6.09%
controls:3.13%
cases:6.08%
controls:1.79%
cases:2.78%
controls:0.29%
—
—
cases:2.38%
controls:0.32%
cases:6.15%
controls:1.96%
cases:10.66%
controls:5.35%
59
303
910
9365
59
173
911
9501
27
28
943
9646
—
23
31
942
9610
56
183
854
9152
77
408
645
7225
Bacterial infection, unspecified
A49.9 [45590816]
5.5e-01
1.6e+00
2.3e+00
—
2.5e+00
1.9e+00
7.7e-02
cases:1.86%
controls:1.08%
cases:1.86%
controls:0.39%
cases:0.72%
controls:0.07%
—
—
cases:0.73%
controls:0.06%
cases:2.75%
controls:0.44%
cases:1.39%
controls:1.28%
18
104
951
9564
18
38
952
9636
7
7
963
9667
—
7
6
958
9635
25
41
885
9294
10
98
712
7535
Standard cardiac ultrasound examination
FM1AE [2001303278]
6.7e-01
9.7e-01
2.0e+00
1.0e+50
2.1e+00
1.5e+00
9.7e-01
cases:6.30%
controls:3.33%
cases:3.40%
controls:1.32%
cases:1.03%
controls:0.14%
cases:0.52%
controls:0.00%
cases:1.14%
controls:0.15%
cases:5.05%
controls:1.12%
cases:8.03%
controls:3.20%
61
322
908
9346
33
128
937
9546
10
14
960
9660
5
0
965
9674
11
14
954
9627
46
105
864
9230
58
244
664
7389
Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]
—
1.7e+00
—
1.0e+50
3.2e+00
2.7e+00
2.2e+00
—
—
cases:0.62%
controls:0.11%
—
—
cases:0.62%
controls:0.00%
cases:1.24%
controls:0.05%
cases:1.76%
controls:0.12%
cases:1.94%
controls:0.21%
—
6
11
964
9663
—
6
0
964
9674
12
5
953
9636
16
11
894
9324
14
16
708
7617
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
5.4e-01
2.0e+00
3.8e+00
1.0e+50
—
1.2e+00
7.0e-01
cases:4.95%
controls:2.96%
cases:5.05%
controls:0.74%
cases:2.16%
controls:0.05%
cases:0.62%
controls:0.00%
—
—
cases:2.75%
controls:0.85%
cases:5.26%
controls:2.69%
48
286
921
9382
49
72
921
9602
21
5
949
9669
6
0
964
9674
—
25
79
885
9256
38
205
684
7428
Thorax X-ray examination
GD1AA [2001303617]
4.6e-01
1.2e+00
2.3e+00
—
1.9e+00
1.5e+00
8.1e-01
cases:13.83%
controls:9.18%
cases:9.38%
controls:2.97%
cases:3.71%
controls:0.40%
—
—
cases:3.32%
controls:0.52%
cases:12.31%
controls:3.04%
cases:20.78%
controls:10.49%
134
888
835
8780
91
287
879
9387
36
39
934
9635
—
32
50
933
9591
112
284
798
9051
150
801
572
6832
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
3.5e-01
9.1e-01
2.2e+00
1.0e+50
2.9e+00
1.5e+00
5.7e-01
cases:2.27%
controls:1.60%
cases:2.47%
controls:1.01%
cases:1.13%
controls:0.12%
cases:0.72%
controls:0.00%
cases:1.66%
controls:0.09%
cases:3.96%
controls:0.89%
cases:6.37%
controls:3.72%
22
155
947
9513
24
98
946
9576
11
12
959
9662
7
0
963
9674
16
9
949
9632
36
83
874
9252
46
284
676
7349
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
6.3e-01
1.7e+00
3.2e+00
—
—
1.4e+00
1.1e+00
cases:6.60%
controls:3.63%
cases:6.19%
controls:1.18%
cases:2.68%
controls:0.11%
—
—
—
—
cases:4.29%
controls:1.05%
cases:10.94%
controls:3.83%
64
351
905
9317
60
114
910
9560
26
11
944
9663
—
—
39
98
871
9237
79
292
643
7341
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.2e+00
1.6e+00
3.0e+00
—
—
1.2e+00
1.0e+00
cases:5.26%
controls:1.70%
cases:2.99%
controls:0.63%
cases:1.03%
controls:0.05%
—
—
—
—
cases:2.75%
controls:0.80%
cases:6.65%
controls:2.44%
51
164
918
9504
29
61
941
9613
10
5
960
9669
—
—
25
75
885
9260
48
186
674
7447
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
4.7e-01
8.9e-01
1.9e+00
—
2.6e+00
1.6e+00
1.0e+00
cases:5.06%
controls:3.22%
cases:3.61%
controls:1.51%
cases:1.75%
controls:0.28%
—
—
cases:3.11%
controls:0.23%
cases:6.59%
controls:1.44%
cases:9.83%
controls:3.68%
49
311
920
9357
35
146
935
9528
17
27
953
9647
—
30
22
935
9619
60
134
850
9201
71
281
651
7352
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
6.4e-01
1.2e+00
2.2e+00
—
1.9e+00
1.1e+00
8.8e-01
cases:11.46%
controls:6.39%
cases:9.59%
controls:3.08%
cases:4.12%
controls:0.45%
—
—
cases:3.32%
controls:0.49%
cases:9.01%
controls:3.24%
cases:17.45%
controls:8.08%
111
618
858
9050
93
298
877
9376
40
44
930
9630
—
32
47
933
9594
82
302
828
9033
126
617
596
7016
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
4.4e-01
8.9e-01
2.4e+00
—
2.5e+00
1.2e+00
9.9e-01
cases:5.78%
controls:3.81%
cases:3.71%
controls:1.55%
cases:1.86%
controls:0.18%
—
—
cases:2.07%
controls:0.18%
cases:5.05%
controls:1.61%
cases:12.47%
controls:5.04%
56
368
913
9300
36
150
934
9524
18
17
952
9657
—
20
17
945
9624
46
150
864
9185
90
385
632
7248
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.9e-01
9.6e-01
2.2e+00
—
2.1e+00
1.2e+00
9.2e-01
cases:16.62%
controls:10.90%
cases:13.92%
controls:5.83%
cases:8.04%
controls:0.98%
—
—
cases:6.63%
controls:0.84%
cases:17.14%
controls:5.61%
cases:27.70%
controls:13.28%
161
1054
808
8614
135
564
835
9110
78
95
892
9579
—
64
81
901
9560
156
524
754
8811
200
1014
522
6619
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
3.9e-01
9.3e-01
2.4e+00
1.0e+50
3.0e+00
1.5e+00
5.5e-01
cases:2.37%
controls:1.61%
cases:2.47%
controls:0.99%
cases:1.13%
controls:0.10%
cases:0.72%
controls:0.00%
cases:1.66%
controls:0.08%
cases:3.74%
controls:0.85%
cases:5.96%
controls:3.51%
23
156
946
9512
24
96
946
9578
11
10
959
9664
7
0
963
9674
16
8
949
9633
34
79
876
9256
43
268
679
7365
Neurology
13 [38004458]
2.3e-01
7.4e-01
1.3e+00
3.0e+00
1.5e+00
7.9e-01
5.3e-01
cases:13.21%
controls:10.79%
cases:8.87%
controls:4.42%
cases:2.78%
controls:0.81%
cases:1.03%
controls:0.05%
cases:2.90%
controls:0.67%
cases:9.01%
controls:4.30%
cases:16.62%
controls:10.52%
128
1043
841
8625
86
428
884
9246
27
78
943
9596
10
5
960
9669
28
65
937
9576
82
401
828
8934
120
803
602
6830
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
5.3e-01
1.2e+00
2.4e+00
—
2.2e+00
8.5e-01
6.2e-01
cases:14.65%
controls:9.22%
cases:13.61%
controls:4.72%
cases:6.19%
controls:0.60%
—
—
cases:3.32%
controls:0.36%
cases:10.00%
controls:4.55%
cases:23.13%
controls:13.97%
142
891
827
8777
132
457
838
9217
60
58
910
9616
—
32
35
933
9606
91
425
819
8910
167
1066
555
6567
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.2e-01
4.3e-01
1.3e+00
4.3e+00
1.1e+00
3.4e-01
2.9e-01
cases:33.02%
controls:30.51%
cases:22.68%
controls:15.96%
cases:6.39%
controls:1.88%
cases:3.71%
controls:0.05%
cases:5.28%
controls:1.91%
cases:20.33%
controls:15.39%
cases:41.97%
controls:35.01%
320
2950
649
6718
220
1544
750
8130
62
182
908
9492
36
5
934
9669
51
184
914
9457
185
1437
725
7898
303
2672
419
4961
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
4.8e-01
2.4e+00
—
1.0e+50
1.0e+50
2.7e+00
2.5e+00
cases:0.93%
controls:0.58%
cases:1.96%
controls:0.18%
—
—
cases:2.78%
controls:0.00%
cases:3.52%
controls:0.00%
cases:2.64%
controls:0.18%
cases:5.82%
controls:0.48%
9
56
960
9612
19
17
951
9657
—
27
0
943
9674
34
0
931
9641
24
17
886
9318
42
37
680
7596
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 [3029080]
1.4e+00
2.5e+00
—
1.0e+50
—
3.3e+00
1.8e+00
cases:0.72%
controls:0.18%
cases:1.03%
controls:0.08%
—
—
cases:2.68%
controls:0.00%
—
—
cases:3.08%
controls:0.12%
cases:2.08%
controls:0.34%
7
17
962
9651
10
8
960
9666
—
26
0
944
9674
—
28
11
882
9324
15
26
707
7607
Supplier / Service Provider
OMOP5117446 [33004]
-4.8e-01
-1.4e-01
4.2e-01
—
2.4e+00
2.9e+00
2.8e+00
cases:19.40%
controls:28.04%
cases:7.01%
controls:8.01%
cases:1.24%
controls:0.82%
—
—
cases:1.24%
controls:0.11%
cases:7.91%
controls:0.49%
cases:18.42%
controls:1.32%
188
2711
781
6957
68
775
902
8899
12
79
958
9595
—
12
11
953
9630
72
46
838
9289
133
101
589
7532
Volume of Urine
28009-9 [3036603]
—
2.7e+00
1.0e+50
—
—
2.8e+00
2.1e+00
—
—
cases:1.34%
controls:0.09%
cases:0.62%
controls:0.00%
—
—
—
—
cases:1.10%
controls:0.06%
cases:1.52%
controls:0.20%
—
13
9
957
9665
6
0
964
9674
—
—
10
6
900
9329
11
15
711
7618
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
4.7e-01
1.4e+00
2.9e+00
—
2.2e+00
8.0e-01
6.9e-01
cases:7.22%
controls:4.64%
cases:4.02%
controls:1.01%
cases:1.96%
controls:0.11%
—
—
cases:0.62%
controls:0.07%
cases:2.09%
controls:0.95%
cases:5.96%
controls:3.09%
70
449
899
9219
39
98
931
9576
19
11
951
9663
—
6
7
959
9634
19
89
891
9246
43
236
679
7397
Laboratory Visit
OMOP4822461 [32036]
1.0e-01
3.5e-01
1.5e+00
4.0e+00
1.3e+00
4.0e-01
9.5e-02
cases:48.50%
controls:46.02%
cases:51.03%
controls:42.28%
cases:40.21%
controls:13.17%
cases:27.53%
controls:0.69%
cases:36.37%
controls:13.35%
cases:53.74%
controls:43.72%
cases:61.08%
controls:58.81%
470
4449
499
5219
495
4090
475
5584
390
1274
580
8400
267
67
703
9607
351
1287
614
8354
489
4081
421
5254
441
4489
281
3144
Blood transfusion
WW500 [2001310603]
—
1.3e+00
—
1.0e+50
3.1e+00
2.8e+00
1.6e+00
—
—
cases:0.52%
controls:0.14%
—
—
cases:0.72%
controls:0.00%
cases:1.14%
controls:0.05%
cases:2.86%
controls:0.17%
cases:1.94%
controls:0.39%
—
5
14
965
9660
—
7
0
963
9674
11
5
954
9636
26
16
884
9319
14
30
708
7603
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
1.1e+00
2.1e+00
—
—
—
2.6e+00
1.7e+00
cases:1.44%
controls:0.51%
cases:1.55%
controls:0.19%
—
—
—
—
—
—
cases:2.20%
controls:0.16%
cases:2.77%
controls:0.52%
14
49
955
9619
15
18
955
9656
—
—
—
20
15
890
9320
20
40
702
7593
INR in Blood by Coagulation assay
34714-6 [3032080]
3.5e-01
6.6e-01
9.4e-01
3.4e+00
9.8e-01
6.7e-01
4.9e-01
cases:16.00%
controls:11.83%
cases:11.65%
controls:6.39%
cases:5.15%
controls:2.08%
cases:2.68%
controls:0.09%
cases:6.11%
controls:2.39%
cases:11.32%
controls:6.13%
cases:21.05%
controls:14.04%
155
1144
814
8524
113
618
857
9056
50
201
920
9473
26
9
944
9665
59
230
906
9411
103
572
807
8763
152
1072
570
6561
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
2.4e-01
9.0e-01
2.2e+00
—
2.5e+00
1.3e+00
5.1e-01
cases:3.10%
controls:2.45%
cases:3.20%
controls:1.32%
cases:1.13%
controls:0.12%
—
—
cases:1.97%
controls:0.17%
cases:4.40%
controls:1.20%
cases:7.62%
controls:4.73%
30
237
939
9431
31
128
939
9546
11
12
959
9662
—
19
16
946
9625
40
112
870
9223
55
361
667
7272
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.1e-01
5.0e-01
1.2e+00
4.4e+00
1.0e+00
3.0e-01
2.0e-01
cases:34.78%
controls:32.43%
cases:28.56%
controls:19.51%
cases:7.73%
controls:2.41%
cases:3.92%
controls:0.05%
cases:6.01%
controls:2.26%
cases:24.62%
controls:19.52%
cases:46.81%
controls:41.98%
337
3135
632
6533
277
1887
693
7787
75
233
895
9441
38
5
932
9669
58
218
907
9423
224
1822
686
7513
338
3204
384
4429
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
1.0e+00
2.4e+00
1.0e+50
1.0e+50
1.0e+50
2.1e+00
1.8e+00
cases:1.65%
controls:0.59%
cases:2.06%
controls:0.19%
cases:1.44%
controls:0.00%
cases:2.37%
controls:0.00%
cases:1.04%
controls:0.00%
cases:1.32%
controls:0.16%
cases:3.32%
controls:0.56%
16
57
953
9611
20
18
950
9656
14
0
956
9674
23
0
947
9674
10
0
955
9641
12
15
898
9320
24
43
698
7590
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
9.9e-02
5.1e-01
1.2e+00
4.4e+00
9.6e-01
3.2e-01
2.3e-01
cases:34.06%
controls:31.87%
cases:27.84%
controls:18.78%
cases:7.22%
controls:2.26%
cases:3.92%
controls:0.05%
cases:5.70%
controls:2.27%
cases:24.07%
controls:18.77%
cases:46.68%
controls:41.03%
330
3081
639
6587
270
1817
700
7857
70
219
900
9455
38
5
932
9669
55
219
910
9422
219
1752
691
7583
337
3132
385
4501
Office Visit
OMOP4822458 [581477]
2.3e-01
9.9e-01
1.9e+00
—
2.7e+00
1.1e+00
6.3e-01
cases:10.84%
controls:8.84%
cases:5.57%
controls:2.15%
cases:2.47%
controls:0.36%
—
—
cases:2.90%
controls:0.20%
cases:5.38%
controls:1.89%
cases:10.25%
controls:5.74%
105
855
864
8813
54
208
916
9466
24
35
946
9639
—
28
19
937
9622
49
176
861
9159
74
438
648
7195
Bacteria identified in Blood by Culture
600-7 [3023368]
3.6e-01
9.4e-01
2.1e+00
1.0e+50
2.5e+00
1.2e+00
6.0e-01
cases:7.43%
controls:5.31%
cases:5.57%
controls:2.24%
cases:2.27%
controls:0.28%
cases:2.06%
controls:0.00%
cases:3.52%
controls:0.30%
cases:7.36%
controls:2.32%
cases:11.50%
controls:6.66%
72
513
897
9155
54
217
916
9457
22
27
948
9647
20
0
950
9674
34
29
931
9612
67
217
843
9118
83
508
639
7125
Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]
—
2.7e+00
—
—
1.0e+50
2.8e+00
1.9e+00
—
—
cases:1.34%
controls:0.09%
—
—
—
—
cases:1.97%
controls:0.00%
cases:1.21%
controls:0.07%
cases:1.94%
controls:0.30%
—
13
9
957
9665
—
—
19
0
946
9641
11
7
899
9328
14
23
708
7610
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.7e-01
9.1e-01
2.1e+00
—
2.0e+00
1.2e+00
8.2e-01
cases:16.62%
controls:12.08%
cases:14.85%
controls:6.54%
cases:8.14%
controls:1.09%
—
—
cases:7.15%
controls:1.06%
cases:18.02%
controls:6.37%
cases:29.36%
controls:15.54%
161
1168
808
8500
144
633
826
9041
79
105
891
9569
—
69
102
896
9539
164
595
746
8740
212
1186
510
6447
Leukocytes [#/volume] in Urine
30405-5 [3018095]
6.0e-01
1.1e+00
2.1e+00
—
1.9e+00
1.0e+00
6.5e-01
cases:14.04%
controls:8.23%
cases:11.44%
controls:4.25%
cases:5.05%
controls:0.67%
—
—
cases:4.56%
controls:0.72%
cases:11.54%
controls:4.41%
cases:19.94%
controls:11.49%
136
796
833
8872
111
411
859
9263
49
65
921
9609
—
44
69
921
9572
105
412
805
8923
144
877
578
6756
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.7e-01
6.0e-01
1.3e+00
3.1e+00
1.3e+00
6.4e-01
4.0e-01
cases:20.64%
controls:17.98%
cases:14.23%
controls:8.35%
cases:4.64%
controls:1.32%
cases:1.34%
controls:0.06%
cases:4.04%
controls:1.13%
cases:14.95%
controls:8.52%
cases:28.12%
controls:20.78%
200
1738
769
7930
138
808
832
8866
45
128
925
9546
13
6
957
9668
39
109
926
9532
136
795
774
8540
203
1586
519
6047
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
4.7e-01
1.5e+00
2.9e+00
1.0e+50
—
1.6e+00
1.3e+00
cases:3.51%
controls:2.22%
cases:3.20%
controls:0.76%
cases:2.06%
controls:0.11%
cases:3.20%
controls:0.00%
—
—
cases:3.52%
controls:0.70%
cases:6.65%
controls:1.98%
34
215
935
9453
31
74
939
9600
20
11
950
9663
31
0
939
9674
—
32
65
878
9270
48
151
674
7482
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
—
2.3e+00
—
—
—
2.7e+00
2.3e+00
—
—
cases:1.34%
controls:0.13%
—
—
—
—
—
—
cases:1.98%
controls:0.14%
cases:2.22%
controls:0.24%
—
13
13
957
9661
—
—
—
18
13
892
9322
16
18
706
7615
Osmolality of Urine
2695-5 [3026782]
4.9e-01
1.0e+00
2.0e+00
—
2.2e+00
7.1e-01
7.3e-01
cases:7.74%
controls:4.90%
cases:4.54%
controls:1.72%
cases:1.65%
controls:0.22%
—
—
cases:1.66%
controls:0.19%
cases:3.19%
controls:1.60%
cases:8.86%
controls:4.47%
75
474
894
9194
44
166
926
9508
16
21
954
9653
—
16
18
949
9623
29
149
881
9186
64
341
658
7292
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
3.0e-01
7.6e-01
2.3e+00
—
2.3e+00
1.1e+00
7.0e-01
cases:6.19%
controls:4.65%
cases:4.43%
controls:2.13%
cases:2.68%
controls:0.28%
—
—
cases:2.80%
controls:0.30%
cases:6.04%
controls:2.02%
cases:10.11%
controls:5.28%
60
450
909
9218
43
206
927
9468
26
27
944
9647
—
27
29
938
9612
55
189
855
9146
73
403
649
7230
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.5e-01
1.1e+00
2.1e+00
—
1.8e+00
9.9e-01
7.0e-01
cases:12.18%
controls:7.40%
cases:9.79%
controls:3.59%
cases:4.12%
controls:0.55%
—
—
cases:3.32%
controls:0.59%
cases:9.23%
controls:3.64%
cases:17.73%
controls:9.71%
118
715
851
8953
95
347
875
9327
40
53
930
9621
—
32
57
933
9584
84
340
826
8995
128
741
594
6892
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
7.6e-01
2.5e+00
1.0e+50
1.0e+50
1.0e+50
2.4e+00
2.2e+00
cases:1.03%
controls:0.49%
cases:1.86%
controls:0.16%
cases:1.13%
controls:0.00%
cases:1.03%
controls:0.00%
cases:1.97%
controls:0.00%
cases:2.09%
controls:0.19%
cases:3.60%
controls:0.42%
10
47
959
9621
18
15
952
9659
11
0
959
9674
10
0
960
9674
19
0
946
9641
19
18
891
9317
26
32
696
7601
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.3e-01
4.7e-01
1.1e+00
4.4e+00
8.4e-01
2.9e-01
1.7e-01
cases:37.25%
controls:34.18%
cases:31.44%
controls:22.31%
cases:7.94%
controls:2.82%
cases:3.92%
controls:0.05%
cases:6.01%
controls:2.68%
cases:27.91%
controls:22.50%
cases:49.45%
controls:45.13%
361
3305
608
6363
305
2158
665
7516
77
273
893
9401
38
5
932
9669
58
258
907
9383
254
2100
656
7235
357
3445
365
4188
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
6.6e-01
2.6e+00
1.0e+50
1.0e+50
1.0e+50
2.3e+00
2.1e+00
cases:1.03%
controls:0.54%
cases:2.16%
controls:0.17%
cases:1.44%
controls:0.00%
cases:2.16%
controls:0.00%
cases:2.59%
controls:0.00%
cases:1.87%
controls:0.18%
cases:3.32%
controls:0.42%
10
52
959
9616
21
16
949
9658
14
0
956
9674
21
0
949
9674
25
0
940
9641
17
17
893
9318
24
32
698
7601
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
—
2.2e+00
—
—
—
2.7e+00
2.2e+00
—
—
cases:1.34%
controls:0.16%
—
—
—
—
—
—
cases:2.09%
controls:0.15%
cases:2.22%
controls:0.26%
—
13
15
957
9659
—
—
—
19
14
891
9321
16
20
706
7613
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
4.6e-01
9.9e-01
1.9e+00
—
1.9e+00
9.3e-01
7.3e-01
cases:13.00%
controls:8.63%
cases:10.10%
controls:4.01%
cases:4.02%
controls:0.61%
—
—
cases:3.52%
controls:0.54%
cases:9.23%
controls:3.85%
cases:19.11%
controls:10.26%
126
834
843
8834
98
388
872
9286
39
59
931
9615
—
34
52
931
9589
84
359
826
8976
138
783
584
6850
Immunohistochemistry procedure
117617002 [4035726]
6.7e-01
1.3e+00
—
1.0e+50
3.0e+00
1.9e+00
7.4e-01
cases:3.20%
controls:1.67%
cases:1.96%
controls:0.52%
—
—
cases:2.27%
controls:0.00%
cases:1.66%
controls:0.08%
cases:2.64%
controls:0.42%
cases:2.63%
controls:1.27%
31
161
938
9507
19
50
951
9624
—
22
0
948
9674
16
8
949
9633
24
39
886
9296
19
97
703
7536
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
3.6e-01
2.2e+00
—
—
—
2.6e+00
2.1e+00
cases:0.52%
controls:0.36%
cases:1.34%
controls:0.16%
—
—
—
—
—
—
cases:1.98%
controls:0.15%
cases:2.35%
controls:0.29%
5
35
964
9633
13
15
957
9659
—
—
—
18
14
892
9321
17
22
705
7611
Intravenous
ZX120 [2001311495]
9.8e-01
1.0e+00
—
—
2.1e+00
2.2e+00
1.5e+00
cases:2.68%
controls:1.02%
cases:0.93%
controls:0.34%
—
—
—
—
cases:0.83%
controls:0.10%
cases:3.30%
controls:0.37%
cases:3.60%
controls:0.81%
26
99
943
9569
9
33
961
9641
—
—
8
10
957
9631
30
35
880
9300
26
62
696
7571
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.4e+00
2.1e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:0.93%
controls:0.23%
cases:1.65%
controls:0.21%
—
—
cases:0.52%
controls:0.00%
—
—
cases:1.76%
controls:0.11%
cases:2.08%
controls:0.33%
9
22
960
9646
16
20
954
9654
—
5
0
965
9674
—
16
10
894
9325
15
25
707
7608
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 [3013201]
—
2.2e+00
1.0e+50
1.0e+50
1.0e+50
2.6e+00
2.0e+00
—
—
cases:0.62%
controls:0.07%
cases:1.34%
controls:0.00%
cases:2.58%
controls:0.00%
cases:1.66%
controls:0.00%
cases:1.10%
controls:0.09%
cases:1.11%
controls:0.14%
—
6
7
964
9667
13
0
957
9674
25
0
945
9674
16
0
949
9641
10
8
900
9327
8
11
714
7622
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
1.0e+00
2.6e+00
—
—
—
2.0e+00
1.2e+00
cases:1.55%
controls:0.56%
cases:1.96%
controls:0.16%
—
—
—
—
—
—
cases:0.99%
controls:0.14%
cases:1.80%
controls:0.55%
15
54
954
9614
19
15
951
9659
—
—
—
9
13
901
9322
13
42
709
7591
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
3.7e-01
9.6e-01
1.8e+00
—
2.3e+00
6.9e-01
6.2e-01
cases:11.04%
controls:7.93%
cases:8.14%
controls:3.29%
cases:3.09%
controls:0.51%
—
—
cases:3.63%
controls:0.38%
cases:6.70%
controls:3.48%
cases:15.10%
controls:8.74%
107
767
862
8901
79
318
891
9356
30
49
940
9625
—
35
37
930
9604
61
325
849
9010
109
667
613
6966
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
5.4e-01
2.2e+00
—
—
1.0e+50
2.7e+00
1.8e+00
cases:0.52%
controls:0.30%
cases:1.03%
controls:0.11%
—
—
—
—
cases:1.04%
controls:0.00%
cases:0.77%
controls:0.05%
cases:1.39%
controls:0.22%
5
29
964
9639
10
11
960
9663
—
—
10
0
955
9641
7
5
903
9330
10
17
712
7616
Base excess in Venous blood by calculation
1927-3 [3002032]
6.3e-01
9.4e-01
2.1e+00
1.0e+50
1.7e+00
1.3e+00
7.1e-01
cases:3.30%
controls:1.79%
cases:2.37%
controls:0.94%
cases:1.44%
controls:0.19%
cases:0.72%
controls:0.00%
cases:1.35%
controls:0.24%
cases:3.85%
controls:1.11%
cases:5.68%
controls:2.87%
32
173
937
9495
23
91
947
9583
14
18
956
9656
7
0
963
9674
13
23
952
9618
35
104
875
9231
41
219
681
7414
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.0e+00
1.2e+00
—
—
2.6e+00
2.0e+00
2.1e+00
cases:0.93%
controls:0.33%
cases:0.82%
controls:0.26%
—
—
—
—
cases:0.83%
controls:0.06%
cases:1.76%
controls:0.25%
cases:1.94%
controls:0.24%
9
32
960
9636
8
25
962
9649
—
—
8
6
957
9635
16
23
894
9312
14
18
708
7615
Atherosclerosis of arteries of extremities
I70.2 [45538421]
4.9e-01
8.9e-01
1.9e+00
—
1.9e+00
9.6e-01
1.1e+00
cases:2.27%
controls:1.41%
cases:1.96%
controls:0.82%
cases:1.34%
controls:0.20%
—
—
cases:1.24%
controls:0.20%
cases:2.42%
controls:0.94%
cases:4.85%
controls:1.73%
22
136
947
9532
19
79
951
9595
13
19
957
9655
—
12
19
953
9622
22
88
888
9247
35
132
687
7501
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
5.3e-01
9.1e-01
1.9e+00
—
1.9e+00
1.1e+00
8.1e-01
cases:2.89%
controls:1.73%
cases:2.68%
controls:1.10%
cases:1.24%
controls:0.19%
—
—
cases:0.83%
controls:0.12%
cases:3.08%
controls:1.08%
cases:4.71%
controls:2.15%
28
167
941
9501
26
106
944
9568
12
18
958
9656
—
8
12
957
9629
28
101
882
9234
34
164
688
7469
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
6.2e-01
2.4e+00
—
—
1.0e+50
2.5e+00
1.7e+00
cases:0.52%
controls:0.28%
cases:1.13%
controls:0.10%
—
—
—
—
cases:0.83%
controls:0.00%
cases:0.77%
controls:0.06%
cases:1.25%
controls:0.24%
5
27
964
9641
11
10
959
9664
—
—
8
0
957
9641
7
6
903
9329
9
18
713
7615
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
6.2e-01
9.2e-01
2.0e+00
1.0e+50
1.8e+00
1.2e+00
6.4e-01
cases:3.30%
controls:1.80%
cases:2.37%
controls:0.96%
cases:1.44%
controls:0.20%
cases:0.82%
controls:0.00%
cases:1.35%
controls:0.23%
cases:3.85%
controls:1.18%
cases:5.54%
controls:2.99%
32
174
937
9494
23
93
947
9581
14
19
956
9655
8
0
962
9674
13
22
952
9619
35
110
875
9225
40
228
682
7405
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
9.2e-01
2.4e+00
—
1.0e+50
1.0e+50
2.3e+00
1.8e+00
cases:0.93%
controls:0.37%
cases:1.65%
controls:0.16%
—
—
cases:1.44%
controls:0.00%
cases:1.35%
controls:0.00%
cases:2.09%
controls:0.20%
cases:2.91%
controls:0.48%
9
36
960
9632
16
15
954
9659
—
14
0
956
9674
13
0
952
9641
19
19
891
9316
21
37
701
7596
Reticulocyte production index
31111-8 [3000012]
9.2e-01
2.2e+00
—
1.0e+50
—
2.7e+00
1.6e+00
cases:0.52%
controls:0.21%
cases:0.93%
controls:0.10%
—
—
cases:1.65%
controls:0.00%
—
—
cases:2.31%
controls:0.16%
cases:1.52%
controls:0.30%
5
20
964
9648
9
10
961
9664
—
16
0
954
9674
—
21
15
889
9320
11
23
711
7610
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
1.7e-01
6.8e-01
1.4e+00
3.8e+00
6.2e-01
1.8e-01
2.3e-01
cases:32.51%
controls:28.96%
cases:28.97%
controls:17.11%
cases:8.56%
controls:2.25%
cases:2.68%
controls:0.06%
cases:3.73%
controls:2.03%
cases:19.56%
controls:16.84%
cases:42.66%
controls:37.17%
315
2800
654
6868
281
1655
689
8019
83
218
887
9456
26
6
944
9668
36
196
929
9445
178
1572
732
7763
308
2837
414
4796
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
3.8e-01
1.2e+00
2.8e+00
1.0e+50
—
1.4e+00
1.1e+00
cases:3.92%
controls:2.71%
cases:3.30%
controls:1.01%
cases:1.96%
controls:0.12%
cases:2.99%
controls:0.00%
—
—
cases:4.18%
controls:1.02%
cases:7.76%
controls:2.82%
38
262
931
9406
32
98
938
9576
19
12
951
9662
29
0
941
9674
—
38
95
872
9240
56
215
666
7418
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
6.3e-02
7.2e-01
1.9e+00
1.0e+50
2.3e+00
9.8e-01
4.7e-01
cases:10.73%
controls:10.15%
cases:7.94%
controls:4.01%
cases:3.61%
controls:0.54%
cases:2.27%
controls:0.00%
cases:5.08%
controls:0.51%
cases:9.12%
controls:3.63%
cases:16.34%
controls:10.87%
104
981
865
8687
77
388
893
9286
35
52
935
9622
22
0
948
9674
49
49
916
9592
83
339
827
8996
118
830
604
6803
CBC panel - Blood by Automated count
58410-2 [40761511]
7.0e-02
3.4e-01
1.1e+00
3.6e+00
1.0e+00
3.8e-01
2.2e-01
cases:37.87%
controls:36.23%
cases:29.38%
controls:22.83%
cases:11.44%
controls:4.25%
cases:6.60%
controls:0.19%
cases:10.88%
controls:4.27%
cases:29.34%
controls:22.05%
cases:47.65%
controls:42.16%
367
3503
602
6165
285
2209
685
7465
111
411
859
9263
64
18
906
9656
105
412
860
9229
267
2058
643
7277
344
3218
378
4415
Granulocytes [#/volume] in Blood
30394-1 [3035715]
1.0e+00
2.5e+00
—
1.0e+50
—
2.2e+00
1.7e+00
cases:1.14%
controls:0.41%
cases:1.13%
controls:0.09%
—
—
cases:0.62%
controls:0.00%
—
—
cases:0.66%
controls:0.07%
cases:1.25%
controls:0.22%
11
40
958
9628
11
9
959
9665
—
6
0
964
9674
—
6
7
904
9328
9
17
713
7616
pH of Venous blood
2746-6 [3012544]
5.7e-01
8.6e-01
2.0e+00
1.0e+50
1.8e+00
1.1e+00
7.0e-01
cases:3.20%
controls:1.84%
cases:2.27%
controls:0.97%
cases:1.44%
controls:0.20%
cases:0.93%
controls:0.00%
cases:1.24%
controls:0.22%
cases:3.52%
controls:1.20%
cases:5.54%
controls:2.83%
31
178
938
9490
22
94
948
9580
14
19
956
9655
9
0
961
9674
12
21
953
9620
32
112
878
9223
40
216
682
7417
Gastroenterology
10 [38004455]
3.7e-01
8.6e-01
1.5e+00
1.0e+50
1.7e+00
1.3e+00
9.8e-01
cases:8.15%
controls:5.76%
cases:6.08%
controls:2.67%
cases:1.86%
controls:0.42%
cases:0.72%
controls:0.00%
cases:2.28%
controls:0.40%
cases:8.35%
controls:2.34%
cases:14.82%
controls:6.13%
79
557
890
9111
59
258
911
9416
18
41
952
9633
7
0
963
9674
22
39
943
9602
76
218
834
9117
107
468
615
7165
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
6.2e-01
2.1e+00
—
1.0e+50
—
2.2e+00
2.1e+00
cases:0.52%
controls:0.28%
cases:1.24%
controls:0.16%
—
—
cases:0.72%
controls:0.00%
—
—
cases:1.32%
controls:0.15%
cases:2.08%
controls:0.25%
5
27
964
9641
12
15
958
9659
—
7
0
963
9674
—
12
14
898
9321
15
19
707
7614
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.8e-01
1.2e+00
2.3e+00
—
1.6e+00
5.3e-01
4.7e-01
cases:26.21%
controls:21.15%
cases:28.04%
controls:10.42%
cases:12.47%
controls:1.37%
—
—
cases:6.94%
controls:1.49%
cases:15.60%
controls:9.78%
cases:33.52%
controls:23.99%
254
2045
715
7623
272
1008
698
8666
121
133
849
9541
—
67
144
898
9497
142
913
768
8422
242
1831
480
5802
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
6.2e-01
1.2e+00
1.5e+00
—
1.6e+00
1.3e+00
7.8e-01
cases:3.51%
controls:1.91%
cases:3.51%
controls:1.13%
cases:1.44%
controls:0.33%
—
—
cases:1.45%
controls:0.30%
cases:4.18%
controls:1.15%
cases:5.12%
controls:2.42%
34
185
935
9483
34
109
936
9565
14
32
956
9642
—
14
29
951
9612
38
107
872
9228
37
185
685
7448
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.2e-01
9.2e-01
2.3e+00
—
2.2e+00
8.5e-01
4.8e-01
cases:4.02%
controls:2.67%
cases:2.78%
controls:1.13%
cases:1.03%
controls:0.10%
—
—
cases:1.04%
controls:0.11%
cases:2.42%
controls:1.05%
cases:4.57%
controls:2.87%
39
258
930
9410
27
109
943
9565
10
10
960
9664
—
10
11
955
9630
22
98
888
9237
33
219
689
7414
Thrombin time
3243-3 [3036489]
7.0e-01
2.0e+00
1.0e+50
1.0e+50
1.0e+50
2.3e+00
1.8e+00
cases:1.34%
controls:0.67%
cases:1.86%
controls:0.25%
cases:1.03%
controls:0.00%
cases:0.93%
controls:0.00%
cases:1.97%
controls:0.00%
cases:2.09%
controls:0.20%
cases:3.60%
controls:0.59%
13
65
956
9603
18
24
952
9650
10
0
960
9674
9
0
961
9674
19
0
946
9641
19
19
891
9316
26
45
696
7588
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.8e-01
6.1e-01
1.8e+00
—
1.7e+00
9.3e-01
8.2e-01
cases:10.42%
controls:7.40%
cases:5.88%
controls:3.29%
cases:3.30%
controls:0.56%
—
—
cases:2.80%
controls:0.54%
cases:7.14%
controls:2.96%
cases:18.14%
controls:8.87%
101
715
868
8953
57
318
913
9356
32
54
938
9620
—
27
52
938
9589
65
276
845
9059
131
677
591
6956
Protein electrophoresis panel - 24 hour Urine
81231-3 [21494890]
—
—
1.0e+50
—
—
3.6e+00
2.6e+00
—
—
—
—
cases:1.55%
controls:0.00%
—
—
—
—
cases:1.87%
controls:0.05%
cases:2.22%
controls:0.17%
—
—
15
0
955
9674
—
—
17
5
893
9330
16
13
706
7620
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
4.8e-01
2.0e+00
—
1.0e+50
—
2.1e+00
2.0e+00
cases:0.52%
controls:0.32%
cases:1.24%
controls:0.17%
—
—
cases:0.72%
controls:0.00%
—
—
cases:1.32%
controls:0.16%
cases:2.08%
controls:0.29%
5
31
964
9637
12
16
958
9658
—
7
0
963
9674
—
12
15
898
9320
15
22
707
7611
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
2.4e-01
5.4e-01
1.2e+00
3.4e+00
6.8e-01
2.7e-01
1.7e-01
cases:33.13%
controls:28.01%
cases:28.76%
controls:19.09%
cases:8.04%
controls:2.51%
cases:1.86%
controls:0.06%
cases:4.66%
controls:2.43%
cases:23.41%
controls:18.95%
cases:43.35%
controls:39.30%
321
2708
648
6960
279
1847
691
7827
78
243
892
9431
18
6
952
9668
45
234
920
9407
213
1769
697
7566
313
3000
409
4633
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
5.4e-01
2.4e+00
1.0e+50
1.0e+50
1.0e+50
2.0e+00
1.5e+00
cases:0.52%
controls:0.30%
cases:1.65%
controls:0.14%
cases:0.72%
controls:0.00%
cases:2.16%
controls:0.00%
cases:0.83%
controls:0.00%
cases:0.77%
controls:0.11%
cases:2.49%
controls:0.56%
5
29
964
9639
16
14
954
9660
7
0
963
9674
21
0
949
9674
8
0
957
9641
7
10
903
9325
18
43
704
7590
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2.4e-02
8.7e-01
1.9e+00
—
2.0e+00
7.0e-01
4.5e-01
cases:6.71%
controls:6.56%
cases:6.19%
controls:2.68%
cases:1.75%
controls:0.27%
—
—
cases:1.76%
controls:0.24%
cases:4.51%
controls:2.28%
cases:11.91%
controls:7.95%
65
634
904
9034
60
259
910
9415
17
26
953
9648
—
17
23
948
9618
41
213
869
9122
86
607
636
7026
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
4.7e-01
9.5e-01
1.8e+00
—
2.0e+00
7.0e-01
3.6e-01
cases:7.33%
controls:4.73%
cases:6.60%
controls:2.66%
cases:2.06%
controls:0.33%
—
—
cases:2.38%
controls:0.34%
cases:5.93%
controls:3.03%
cases:11.91%
controls:8.63%
71
457
898
9211
64
257
906
9417
20
32
950
9642
—
23
33
942
9608
54
283
856
9052
86
659
636
6974
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
9.1e-01
1.4e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:2.06%
controls:0.84%
cases:1.03%
controls:0.25%
—
—
cases:1.86%
controls:0.00%
—
—
cases:1.76%
controls:0.21%
cases:4.02%
controls:0.97%
20
81
949
9587
10
24
960
9650
—
18
0
952
9674
—
16
20
894
9315
29
74
693
7559
Emergency Room Visit
ER [9203]
3.4e-01
8.4e-01
1.8e+00
—
1.3e+00
8.1e-01
6.4e-01
cases:40.97%
controls:33.02%
cases:21.44%
controls:10.52%
cases:7.22%
controls:1.24%
—
—
cases:4.77%
controls:1.29%
cases:19.45%
controls:9.71%
cases:41.97%
controls:27.62%
397
3192
572
6476
208
1018
762
8656
70
120
900
9554
—
46
124
919
9517
177
906
733
8429
303
2108
419
5525
Case Management Agency
251B00000X [38004193]
6.5e-02
1.8e-01
7.8e-01
3.7e+00
8.8e-01
3.9e-01
1.8e-01
cases:67.08%
controls:65.64%
cases:63.30%
controls:58.96%
cases:41.55%
controls:24.54%
cases:38.97%
controls:1.50%
cases:44.25%
controls:24.83%
cases:69.67%
controls:60.80%
cases:78.81%
controls:75.72%
650
6346
319
3322
614
5704
356
3970
403
2374
567
7300
378
145
592
9529
427
2394
538
7247
634
5676
276
3659
569
5780
153
1853
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
7.7e-01
2.5e+00
—
1.0e+50
—
1.8e+00
1.5e+00
cases:1.14%
controls:0.53%
cases:1.24%
controls:0.10%
—
—
cases:0.62%
controls:0.00%
—
—
cases:0.77%
controls:0.13%
cases:1.25%
controls:0.29%
11
51
958
9617
12
10
958
9664
—
6
0
964
9674
—
7
12
903
9323
9
22
713
7611
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
—
—
—
—
—
3.4e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.05%
cases:1.80%
controls:0.17%
—
—
—
—
—
14
5
896
9330
13
13
709
7620
Inpatient Hospital
21 [8717]
1.8e-01
6.7e-01
1.5e+00
—
1.9e+00
9.7e-01
6.9e-01
cases:33.54%
controls:29.58%
cases:15.88%
controls:8.79%
cases:5.36%
controls:1.21%
—
—
cases:6.53%
controls:1.07%
cases:17.80%
controls:7.56%
cases:34.35%
controls:20.75%
325
2860
644
6808
154
850
816
8824
52
117
918
9557
—
63
103
902
9538
162
706
748
8629
248
1584
474
6049
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
1.1e+00
1.8e+00
—
—
—
1.7e+00
1.1e+00
cases:1.75%
controls:0.61%
cases:1.44%
controls:0.25%
—
—
—
—
—
—
cases:1.32%
controls:0.24%
cases:1.94%
controls:0.63%
17
59
952
9609
14
24
956
9650
—
—
—
12
22
898
9313
14
48
708
7585
Karyotype in Bone marrow
81861-7 [21494434]
2.2e+00
—
1.0e+50
1.0e+50
—
—
3.4e+00
cases:1.44%
controls:0.16%
—
—
cases:1.44%
controls:0.00%
cases:8.66%
controls:0.00%
—
—
—
—
cases:3.05%
controls:0.10%
14
15
955
9653
—
14
0
956
9674
84
0
886
9674
—
—
22
8
700
7625
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.0e+00
1.8e+00
—
—
—
1.6e+00
1.2e+00
cases:1.75%
controls:0.63%
cases:1.44%
controls:0.25%
—
—
—
—
—
—
cases:1.32%
controls:0.26%
cases:1.94%
controls:0.62%
17
61
952
9607
14
24
956
9650
—
—
—
12
24
898
9311
14
47
708
7586
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
5.7e-01
1.1e+00
—
—
3.0e+00
2.6e+00
9.3e-01
cases:0.62%
controls:0.35%
cases:0.62%
controls:0.22%
—
—
—
—
cases:1.04%
controls:0.05%
cases:1.65%
controls:0.13%
cases:1.25%
controls:0.50%
6
34
963
9634
6
21
964
9653
—
—
10
5
955
9636
15
12
895
9323
9
38
713
7595
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
-2.3e-03
1.7e+00
—
1.0e+50
—
2.0e+00
1.8e+00
cases:0.52%
controls:0.52%
cases:1.24%
controls:0.23%
—
—
cases:0.82%
controls:0.00%
—
—
cases:1.43%
controls:0.19%
cases:2.22%
controls:0.38%
5
50
964
9618
12
22
958
9652
—
8
0
962
9674
—
13
18
897
9317
16
29
706
7604
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
5.1e-01
1.2e+00
—
—
2.9e+00
2.6e+00
1.0e+00
cases:0.62%
controls:0.37%
cases:0.62%
controls:0.20%
—
—
—
—
cases:0.93%
controls:0.05%
cases:1.54%
controls:0.12%
cases:1.25%
controls:0.46%
6
36
963
9632
6
19
964
9655
—
—
9
5
956
9636
14
11
896
9324
9
35
713
7598
Ulcerative colitis, unspecified
K51.9 [45605941]
1.4e+00
1.3e+00
—
—
—
2.5e+00
1.6e+00
cases:1.14%
controls:0.29%
cases:0.52%
controls:0.13%
—
—
—
—
—
—
cases:0.99%
controls:0.09%
cases:1.11%
controls:0.22%
11
28
958
9640
5
13
965
9661
—
—
—
9
8
901
9327
8
17
714
7616
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
1.1e+00
—
—
—
—
3.4e+00
2.1e+00
cases:0.52%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.05%
cases:1.52%
controls:0.20%
5
17
964
9651
—
—
—
—
14
5
896
9330
11
15
711
7618
Outpatient Hospital
22 [8756]
1.6e-01
5.7e-01
1.4e+00
—
1.8e+00
1.1e+00
6.2e-01
cases:26.73%
controls:23.67%
cases:10.52%
controls:6.25%
cases:3.20%
controls:0.85%
—
—
cases:4.25%
controls:0.71%
cases:13.19%
controls:5.01%
cases:25.62%
controls:15.58%
259
2288
710
7380
102
605
868
9069
31
82
939
9592
—
41
68
924
9573
120
468
790
8867
185
1189
537
6444
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
1.6e-01
6.7e-01
1.5e+00
—
1.7e+00
1.0e+00
5.2e-01
cases:16.10%
controls:14.02%
cases:12.06%
controls:6.57%
cases:4.33%
controls:0.97%
—
—
cases:5.28%
controls:1.04%
cases:16.48%
controls:6.58%
cases:26.32%
controls:17.56%
156
1355
813
8313
117
636
853
9038
42
94
928
9580
—
51
100
914
9541
150
614
760
8721
190
1340
532
6293
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
4.8e-01
7.3e-01
1.4e+00
—
1.3e+00
8.9e-01
6.6e-01
cases:11.25%
controls:7.24%
cases:6.39%
controls:3.18%
cases:2.16%
controls:0.56%
—
—
cases:1.87%
controls:0.53%
cases:7.80%
controls:3.35%
cases:13.99%
controls:7.74%
109
700
860
8968
62
308
908
9366
21
54
949
9620
—
18
51
947
9590
71
313
839
9022
101
591
621
7042
Cathetrisation of vein
TPH04 [2001309597]
4.6e-01
9.1e-01
1.8e+00
—
1.8e+00
8.5e-01
5.8e-01
cases:4.95%
controls:3.19%
cases:2.78%
controls:1.14%
cases:1.03%
controls:0.18%
—
—
cases:0.83%
controls:0.13%
cases:2.75%
controls:1.19%
cases:5.68%
controls:3.28%
48
308
921
9360
27
110
943
9564
10
17
960
9657
—
8
13
957
9628
25
111
885
9224
41
250
681
7383
Other specified special examinations
Z01.8 [45581003]
1.6e-01
9.7e-01
2.2e+00
—
—
1.5e+00
6.5e-01
cases:3.61%
controls:3.08%
cases:2.47%
controls:0.95%
cases:1.13%
controls:0.12%
—
—
—
—
cases:3.63%
controls:0.81%
cases:5.96%
controls:3.21%
35
298
934
9370
24
92
946
9582
11
12
959
9662
—
—
33
76
877
9259
43
245
679
7388
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
4.9e-01
9.9e-01
2.2e+00
—
—
1.3e+00
8.5e-01
cases:2.68%
controls:1.67%
cases:1.75%
controls:0.66%
cases:0.72%
controls:0.08%
—
—
—
—
cases:1.98%
controls:0.55%
cases:4.57%
controls:2.00%
26
161
943
9507
17
64
953
9610
7
8
963
9666
—
—
18
51
892
9284
33
153
689
7480
Upper gastrointestinal surgery
106 [44777669]
5.1e-01
6.4e-01
1.4e+00
—
1.4e+00
8.5e-01
5.7e-01
cases:15.89%
controls:10.19%
cases:7.42%
controls:4.04%
cases:2.58%
controls:0.67%
—
—
cases:1.87%
controls:0.48%
cases:8.02%
controls:3.61%
cases:17.04%
controls:10.42%
154
985
815
8683
72
391
898
9283
25
65
945
9609
—
18
46
947
9595
73
337
837
8998
123
795
599
6838
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
6.3e-01
1.7e+00
—
1.0e+50
1.0e+50
2.1e+00
1.5e+00
cases:2.58%
controls:1.39%
cases:2.58%
controls:0.49%
—
—
cases:2.99%
controls:0.00%
cases:2.90%
controls:0.00%
cases:3.30%
controls:0.40%
cases:5.54%
controls:1.34%
25
134
944
9534
25
47
945
9627
—
29
0
941
9674
28
0
937
9641
30
37
880
9298
40
102
682
7531
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
4.6e-01
8.0e-01
1.9e+00
—
1.6e+00
5.4e-01
6.0e-01
cases:7.43%
controls:4.81%
cases:4.33%
controls:1.98%
cases:1.75%
controls:0.28%
—
—
cases:1.55%
controls:0.33%
cases:3.19%
controls:1.89%
cases:9.56%
controls:5.50%
72
465
897
9203
42
192
928
9482
17
27
953
9647
—
15
32
950
9609
29
176
881
9159
69
420
653
7213
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
1.6e+00
1.5e+00
—
—
—
1.9e+00
1.7e+00
cases:0.83%
controls:0.17%
cases:0.62%
controls:0.13%
—
—
—
—
—
—
cases:0.99%
controls:0.15%
cases:1.11%
controls:0.20%
8
16
961
9652
6
13
964
9661
—
—
—
9
14
901
9321
8
15
714
7618
Vascular Surgery
77 [38004496]
2.5e-01
9.3e-01
1.6e+00
—
1.7e+00
9.5e-01
3.9e-01
cases:3.82%
controls:3.01%
cases:2.89%
controls:1.16%
cases:0.93%
controls:0.19%
—
—
cases:0.83%
controls:0.15%
cases:3.08%
controls:1.21%
cases:5.12%
controls:3.52%
37
291
932
9377
28
112
942
9562
9
18
961
9656
—
8
14
957
9627
28
113
882
9222
37
269
685
7364
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
9.5e-02
8.1e-01
1.9e+00
—
1.8e+00
4.3e-01
3.1e-01
cases:17.54%
controls:16.22%
cases:14.95%
controls:7.24%
cases:5.57%
controls:0.88%
—
—
cases:4.66%
controls:0.82%
cases:10.44%
controls:7.06%
cases:25.62%
controls:20.16%
170
1568
799
8100
145
700
825
8974
54
85
916
9589
—
45
79
920
9562
95
659
815
8676
185
1539
537
6094
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
1.2e+00
—
—
—
—
2.3e+00
2.8e+00
cases:0.52%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.07%
cases:1.11%
controls:0.07%
5
15
964
9653
—
—
—
—
7
7
903
9328
8
5
714
7628
Emergency Room and Inpatient Visit
ERIP [262]
3.1e-01
7.6e-01
1.9e+00
—
1.7e+00
7.8e-01
2.6e-01
cases:7.12%
controls:5.33%
cases:6.49%
controls:3.13%
cases:3.09%
controls:0.49%
—
—
cases:3.11%
controls:0.56%
cases:7.80%
controls:3.72%
cases:13.30%
controls:10.53%
69
515
900
9153
63
303
907
9371
30
47
940
9627
—
30
54
935
9587
71
347
839
8988
96
804
626
6829
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
7.0e-01
7.9e-01
—
1.0e+50
2.6e+00
1.7e+00
7.7e-01
cases:1.03%
controls:0.52%
cases:0.93%
controls:0.42%
—
—
cases:0.52%
controls:0.00%
cases:0.73%
controls:0.05%
cases:2.20%
controls:0.40%
cases:4.16%
controls:1.97%
10
50
959
9618
9
41
961
9633
—
5
0
965
9674
7
5
958
9636
20
37
890
9298
30
150
692
7483
Atherosclerotic heart disease
I25.1 [45596196]
-3.2e-01
1.5e-01
7.4e-01
3.8e+00
1.4e+00
3.0e-01
2.9e-02
cases:4.23%
controls:5.73%
cases:3.51%
controls:3.04%
cases:1.03%
controls:0.50%
cases:2.16%
controls:0.05%
cases:2.18%
controls:0.57%
cases:4.07%
controls:3.03%
cases:6.65%
controls:6.47%
41
554
928
9114
34
294
936
9380
10
48
960
9626
21
5
949
9669
21
55
944
9586
37
283
873
9052
48
494
674
7139
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
1.0e+00
2.5e+00
1.0e+50
—
—
2.6e+00
1.3e+00
cases:0.62%
controls:0.23%
cases:0.72%
controls:0.06%
cases:0.82%
controls:0.00%
—
—
—
—
cases:1.10%
controls:0.09%
cases:0.83%
controls:0.24%
6
22
963
9646
7
6
963
9668
8
0
962
9674
—
—
10
8
900
9327
6
18
716
7615
Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]
1.3e+00
1.8e+00
1.0e+50
—
—
2.6e+00
2.4e+00
cases:0.72%
controls:0.20%
cases:0.52%
controls:0.08%
cases:0.52%
controls:0.00%
—
—
—
—
cases:0.88%
controls:0.06%
cases:1.66%
controls:0.16%
7
19
962
9649
5
8
965
9666
5
0
965
9674
—
—
8
6
902
9329
12
12
710
7621
filgrastim; parenteral
L03AA02 [21603851]
—
—
—
—
—
3.1e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.10%
cases:0.97%
controls:0.16%
—
—
—
—
—
20
9
890
9326
7
12
715
7621
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
5.0e-01
1.9e+00
—
—
1.0e+50
1.8e+00
1.3e+00
cases:1.03%
controls:0.63%
cases:1.13%
controls:0.18%
—
—
—
—
cases:0.62%
controls:0.00%
cases:0.77%
controls:0.13%
cases:1.94%
controls:0.54%
10
61
959
9607
11
17
959
9657
—
—
6
0
959
9641
7
12
903
9323
14
41
708
7592
Fungus identified in Specimen by Culture
580-1 [3000494]
5.5e-01
8.9e-01
—
—
2.6e+00
1.3e+00
4.3e-01
cases:4.02%
controls:2.36%
cases:2.16%
controls:0.90%
—
—
—
—
cases:1.14%
controls:0.08%
cases:2.75%
controls:0.76%
cases:3.88%
controls:2.57%
39
228
930
9440
21
87
949
9587
—
—
11
8
954
9633
25
71
885
9264
28
196
694
7437
Iron deficiency anaemia, unspecified
D50.9 [45605373]
1.3e+00
1.2e+00
—
1.0e+50
—
1.3e+00
1.0e+00
cases:2.48%
controls:0.66%
cases:1.65%
controls:0.52%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.43%
controls:0.41%
cases:3.19%
controls:1.15%
24
64
945
9604
16
50
954
9624
—
6
0
964
9674
—
13
38
897
9297
23
88
699
7545
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1.0e+00
1.3e+00
—
1.0e+50
2.1e+00
1.5e+00
9.9e-01
cases:2.79%
controls:1.02%
cases:1.55%
controls:0.43%
—
—
cases:0.52%
controls:0.00%
cases:0.52%
controls:0.06%
cases:2.09%
controls:0.47%
cases:3.60%
controls:1.36%
27
99
942
9569
15
42
955
9632
—
5
0
965
9674
5
6
960
9635
19
44
891
9291
26
104
696
7529
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
1.2e+00
1.9e+00
—
—
—
—
1.7e+00
cases:1.55%
controls:0.48%
cases:0.93%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.35%
15
46
954
9622
9
14
961
9660
—
—
—
—
14
27
708
7606
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
4.8e-01
9.2e-01
1.7e+00
—
1.9e+00
1.2e+00
7.1e-01
cases:3.92%
controls:2.46%
cases:2.68%
controls:1.09%
cases:0.52%
controls:0.09%
—
—
cases:0.83%
controls:0.12%
cases:2.75%
controls:0.81%
cases:4.57%
controls:2.29%
38
238
931
9430
26
105
944
9569
5
9
965
9665
—
8
12
957
9629
25
76
885
9259
33
175
689
7458
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
1.1e-01
6.2e-01
1.7e+00
—
1.7e+00
7.2e-01
2.5e-01
cases:6.81%
controls:6.15%
cases:6.19%
controls:3.41%
cases:2.99%
controls:0.54%
—
—
cases:2.80%
controls:0.53%
cases:7.58%
controls:3.85%
cases:12.60%
controls:10.13%
66
595
903
9073
60
330
910
9344
29
52
941
9622
—
27
51
938
9590
69
359
841
8976
91
773
631
6860
Pure hypercholesterolaemia
E78.01 [2000501514]
1.4e-01
7.5e-01
1.4e+00
1.0e+50
1.9e+00
6.9e-01
4.7e-02
cases:4.44%
controls:3.89%
cases:3.81%
controls:1.84%
cases:1.34%
controls:0.33%
cases:2.27%
controls:0.00%
cases:2.28%
controls:0.34%
cases:4.18%
controls:2.14%
cases:5.96%
controls:5.70%
43
376
926
9292
37
178
933
9496
13
32
957
9642
22
0
948
9674
22
33
943
9608
38
200
872
9135
43
435
679
7198
FEV1 percent change
69983-5 [42868472]
6.3e-01
1.2e+00
—
—
—
1.7e+00
1.3e+00
cases:3.82%
controls:2.08%
cases:2.06%
controls:0.62%
—
—
—
—
—
—
cases:2.20%
controls:0.43%
cases:4.02%
controls:1.18%
37
201
932
9467
20
60
950
9614
—
—
—
20
40
890
9295
29
90
693
7543
FEV1/FVC --post bronchodilation
69970-2 [42868459]
6.3e-01
1.2e+00
—
—
—
1.7e+00
1.3e+00
cases:3.82%
controls:2.08%
cases:2.06%
controls:0.62%
—
—
—
—
—
—
cases:2.20%
controls:0.43%
cases:4.02%
controls:1.18%
37
201
932
9467
20
60
950
9614
—
—
—
20
40
890
9295
29
90
693
7543
FVC percent change Respiratory system
69982-7 [42868471]
6.3e-01
1.2e+00
—
—
—
1.7e+00
1.3e+00
cases:3.82%
controls:2.08%
cases:2.06%
controls:0.62%
—
—
—
—
—
—
cases:2.20%
controls:0.43%
cases:4.02%
controls:1.18%
37
201
932
9467
20
60
950
9614
—
—
—
20
40
890
9295
29
90
693
7543
FEV1 --post bronchodilation
20155-8 [3023550]
6.3e-01
1.2e+00
—
—
—
1.7e+00
1.3e+00
cases:3.82%
controls:2.08%
cases:2.06%
controls:0.62%
—
—
—
—
—
—
cases:2.20%
controls:0.43%
cases:4.02%
controls:1.18%
37
201
932
9467
20
60
950
9614
—
—
—
20
40
890
9295
29
90
693
7543
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
6.3e-01
1.2e+00
—
—
—
1.7e+00
1.3e+00
cases:3.82%
controls:2.08%
cases:2.06%
controls:0.62%
—
—
—
—
—
—
cases:2.20%
controls:0.43%
cases:4.02%
controls:1.18%
37
201
932
9467
20
60
950
9614
—
—
—
20
40
890
9295
29
90
693
7543
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
2.7e-01
6.1e-01
1.9e+00
—
1.8e+00
1.0e+00
-3.1e-02
cases:3.51%
controls:2.71%
cases:1.86%
controls:1.01%
cases:0.72%
controls:0.10%
—
—
cases:0.93%
controls:0.16%
cases:2.64%
controls:0.99%
cases:2.77%
controls:2.86%
34
262
935
9406
18
98
952
9576
7
10
963
9664
—
9
15
956
9626
24
92
886
9243
20
218
702
7415
Tissue Pathology biopsy report
66121-5 [40768804]
5.0e-01
4.2e-01
1.5e+00
—
1.4e+00
7.9e-01
5.0e-01
cases:15.07%
controls:9.72%
cases:4.85%
controls:3.25%
cases:1.34%
controls:0.29%
—
—
cases:1.45%
controls:0.36%
cases:5.82%
controls:2.72%
cases:14.68%
controls:9.45%
146
940
823
8728
47
314
923
9360
13
28
957
9646
—
14
35
951
9606
53
254
857
9081
106
721
616
6912
Left sided colitis
K51.5 [45533604]
1.1e+00
9.8e-01
2.2e+00
—
—
1.3e+00
1.5e+00
cases:1.44%
controls:0.48%
cases:0.93%
controls:0.35%
cases:0.62%
controls:0.07%
—
—
—
—
cases:1.10%
controls:0.30%
cases:1.39%
controls:0.33%
14
46
955
9622
9
34
961
9640
6
7
964
9667
—
—
10
28
900
9307
10
25
712
7608
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
—
—
—
—
—
2.8e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.07%
cases:0.97%
controls:0.14%
—
—
—
—
—
11
7
899
9328
7
11
715
7622
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
—
—
—
—
2.5e+00
2.2e+00
9.0e-01
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.05%
cases:1.21%
controls:0.14%
cases:1.25%
controls:0.51%
—
—
—
—
6
5
959
9636
11
13
899
9322
9
39
713
7594
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
3.8e-01
8.1e-01
—
—
1.7e+00
1.2e+00
8.4e-01
cases:6.91%
controls:4.84%
cases:3.30%
controls:1.49%
—
—
—
—
cases:0.83%
controls:0.15%
cases:4.29%
controls:1.30%
cases:9.42%
controls:4.30%
67
468
902
9200
32
144
938
9530
—
—
8
14
957
9627
39
121
871
9214
68
328
654
7305
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
6.1e-01
1.0e+00
—
—
—
1.6e+00
1.4e+00
cases:4.23%
controls:2.34%
cases:2.16%
controls:0.78%
—
—
—
—
—
—
cases:2.42%
controls:0.49%
cases:4.99%
controls:1.32%
41
226
928
9442
21
75
949
9599
—
—
—
22
46
888
9289
36
101
686
7532
FEV1
20150-9 [3024653]
6.1e-01
1.0e+00
—
—
—
1.6e+00
1.4e+00
cases:4.23%
controls:2.34%
cases:2.16%
controls:0.78%
—
—
—
—
—
—
cases:2.42%
controls:0.49%
cases:4.99%
controls:1.32%
41
226
928
9442
21
75
949
9599
—
—
—
22
46
888
9289
36
101
686
7532
FEV1/FVC
19926-5 [3011505]
6.1e-01
1.0e+00
—
—
—
1.6e+00
1.4e+00
cases:4.23%
controls:2.34%
cases:2.16%
controls:0.78%
—
—
—
—
—
—
cases:2.42%
controls:0.49%
cases:4.99%
controls:1.32%
41
226
928
9442
21
75
949
9599
—
—
—
22
46
888
9289
36
101
686
7532
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
5.9e-01
1.3e+00
—
—
—
3.0e+00
1.7e+00
cases:0.93%
controls:0.52%
cases:0.52%
controls:0.14%
—
—
—
—
—
—
cases:3.96%
controls:0.21%
cases:3.32%
controls:0.66%
9
50
960
9618
5
14
965
9660
—
—
—
36
20
874
9315
24
50
698
7583
Inpatient Visit
IP [9201]
2.5e-01
5.4e-01
1.2e+00
—
1.3e+00
9.0e-01
5.2e-01
cases:9.29%
controls:7.40%
cases:5.77%
controls:3.43%
cases:1.44%
controls:0.42%
—
—
cases:1.76%
controls:0.48%
cases:7.58%
controls:3.21%
cases:15.24%
controls:9.63%
90
715
879
8953
56
332
914
9342
14
41
956
9633
—
17
46
948
9595
69
300
841
9035
110
735
612
6898
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
1.1e+00
1.7e+00
—
—
—
—
1.6e+00
cases:1.44%
controls:0.48%
cases:0.82%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.35%
14
46
955
9622
8
14
962
9660
—
—
—
—
12
27
710
7606
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
4.9e-01
1.3e+00
—
—
—
1.9e+00
1.2e+00
cases:0.93%
controls:0.57%
cases:1.13%
controls:0.31%
—
—
—
—
—
—
cases:1.32%
controls:0.19%
cases:1.80%
controls:0.58%
9
55
960
9613
11
30
959
9644
—
—
—
12
18
898
9317
13
44
709
7589
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
4.6e-01
7.7e-01
1.3e+00
—
9.1e-01
9.7e-01
8.7e-01
cases:11.76%
controls:7.77%
cases:5.88%
controls:2.82%
cases:2.06%
controls:0.57%
—
—
cases:1.45%
controls:0.59%
cases:7.03%
controls:2.79%
cases:14.27%
controls:6.54%
114
751
855
8917
57
273
913
9401
20
55
950
9619
—
14
57
951
9584
64
260
846
9075
103
499
619
7134
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.1e+00
1.1e+00
—
—
—
1.1e+00
1.1e+00
cases:2.48%
controls:0.87%
cases:1.44%
controls:0.49%
—
—
—
—
—
—
cases:1.54%
controls:0.52%
cases:3.88%
controls:1.32%
24
84
945
9584
14
47
956
9627
—
—
—
14
49
896
9286
28
101
694
7532
ECG with 12 standard connections
XF400 [2001303368]
7.9e-01
1.2e+00
—
—
—
1.2e+00
1.1e+00
cases:4.64%
controls:2.17%
cases:1.55%
controls:0.48%
—
—
—
—
—
—
cases:1.87%
controls:0.55%
cases:3.88%
controls:1.30%
45
210
924
9458
15
46
955
9628
—
—
—
17
51
893
9284
28
99
694
7534
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
1.1e+00
2.2e+00
2.1e+00
—
—
2.1e+00
—
cases:0.72%
controls:0.25%
cases:0.82%
controls:0.09%
cases:0.52%
controls:0.06%
—
—
—
—
cases:1.54%
controls:0.18%
—
—
7
24
962
9644
8
9
962
9665
5
6
965
9668
—
—
14
17
896
9318
—
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
6.6e-01
8.3e-01
1.8e+00
1.0e+50
1.3e+00
1.0e+00
5.0e-01
cases:4.23%
controls:2.23%
cases:2.78%
controls:1.23%
cases:1.24%
controls:0.21%
cases:0.62%
controls:0.00%
cases:0.73%
controls:0.21%
cases:3.41%
controls:1.27%
cases:5.82%
controls:3.62%
41
216
928
9452
27
119
943
9555
12
20
958
9654
6
0
964
9674
7
20
958
9621
31
119
879
9216
42
276
680
7357
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
-2.2e-02
7.2e-01
1.4e+00
—
1.5e+00
5.9e-01
1.7e-01
cases:5.06%
controls:5.16%
cases:5.98%
controls:3.01%
cases:2.06%
controls:0.50%
—
—
cases:1.97%
controls:0.45%
cases:5.82%
controls:3.32%
cases:9.83%
controls:8.42%
49
499
920
9169
58
291
912
9383
20
48
950
9626
—
19
43
946
9598
53
310
857
9025
71
643
651
6990
prednisolone; oral, parenteral
H02AB06 [21602734]
4.6e-01
7.1e-01
2.3e-01
—
1.5e+00
8.9e-01
6.7e-01
cases:15.89%
controls:10.70%
cases:9.38%
controls:4.86%
cases:1.24%
controls:0.98%
—
—
cases:3.73%
controls:0.88%
cases:11.32%
controls:4.99%
cases:20.36%
controls:11.61%
154
1034
815
8634
91
470
879
9204
12
95
958
9579
—
36
85
929
9556
103
466
807
8869
147
886
575
6747
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
6.4e-02
6.2e-01
1.5e+00
—
1.6e+00
5.2e-01
2.0e-01
cases:12.07%
controls:11.41%
cases:10.93%
controls:6.20%
cases:4.12%
controls:0.98%
—
—
cases:3.63%
controls:0.77%
cases:10.88%
controls:6.77%
cases:21.19%
controls:17.99%
117
1103
852
8565
106
600
864
9074
40
95
930
9579
—
35
74
930
9567
99
632
811
8703
153
1373
569
6260
prednisolone
A07EA01 [21600653]
4.6e-01
7.0e-01
2.3e-01
—
1.5e+00
8.8e-01
6.5e-01
cases:16.00%
controls:10.72%
cases:9.38%
controls:4.90%
cases:1.24%
controls:0.98%
—
—
cases:3.73%
controls:0.88%
cases:11.32%
controls:5.05%
cases:20.36%
controls:11.73%
155
1036
814
8632
91
474
879
9200
12
95
958
9579
—
36
85
929
9556
103
471
807
8864
147
895
575
6738
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
6.4e-02
6.2e-01
1.5e+00
—
1.6e+00
5.2e-01
2.5e-01
cases:12.38%
controls:11.71%
cases:11.13%
controls:6.32%
cases:4.12%
controls:0.98%
—
—
cases:3.73%
controls:0.81%
cases:10.88%
controls:6.79%
cases:22.02%
controls:17.99%
120
1132
849
8536
108
611
862
9063
40
95
930
9579
—
36
78
929
9563
99
634
811
8701
159
1373
563
6260
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.0e-01
6.0e-01
1.5e+00
—
1.6e+00
5.2e-01
2.3e-01
cases:12.18%
controls:11.12%
cases:10.72%
controls:6.16%
cases:4.12%
controls:0.98%
—
—
cases:3.63%
controls:0.79%
cases:10.77%
controls:6.68%
cases:21.19%
controls:17.57%
118
1075
851
8593
104
596
866
9078
40
95
930
9579
—
35
76
930
9565
98
624
812
8711
153
1341
569
6292
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
2.1e-01
5.5e-01
1.7e+00
—
1.8e+00
5.3e-01
3.1e-01
cases:7.33%
controls:6.00%
cases:4.85%
controls:2.84%
cases:2.06%
controls:0.37%
—
—
cases:1.66%
controls:0.27%
cases:4.73%
controls:2.85%
cases:11.50%
controls:8.66%
71
580
898
9088
47
275
923
9399
20
36
950
9638
—
16
26
949
9615
43
266
867
9069
83
661
639
6972
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
2.3e-01
6.2e-01
1.5e+00
1.0e+50
3.0e+00
1.1e+00
6.6e-01
cases:2.89%
controls:2.31%
cases:1.34%
controls:0.72%
cases:0.52%
controls:0.11%
cases:0.52%
controls:0.00%
cases:1.04%
controls:0.05%
cases:1.98%
controls:0.67%
cases:3.19%
controls:1.68%
28
223
941
9445
13
70
957
9604
5
11
965
9663
5
0
965
9674
10
5
955
9636
18
63
892
9272
23
128
699
7505
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
2.8e-01
1.3e+00
2.3e+00
—
—
3.4e-01
5.0e-01
cases:5.88%
controls:4.53%
cases:4.54%
controls:1.31%
cases:1.03%
controls:0.10%
—
—
—
—
cases:1.65%
controls:1.18%
cases:7.89%
controls:4.95%
57
438
912
9230
44
127
926
9547
10
10
960
9664
—
—
15
110
895
9225
57
378
665
7255
prednisolone
S03BA02 [21605202]
4.7e-01
1.1e+00
2.3e+00
—
-1.0e+50
9.0e-01
6.8e-01
cases:3.20%
controls:2.02%
cases:1.55%
controls:0.53%
cases:0.72%
controls:0.07%
—
—
cases:0.00%
controls:0.06%
cases:1.54%
controls:0.63%
cases:4.29%
controls:2.21%
31
195
938
9473
15
51
955
9623
7
7
963
9667
—
0
6
965
9635
14
59
896
9276
31
169
691
7464
prednisolone
S01BA04 [21603621]
4.7e-01
1.1e+00
2.3e+00
—
-1.0e+50
9.0e-01
6.8e-01
cases:3.20%
controls:2.02%
cases:1.55%
controls:0.53%
cases:0.72%
controls:0.07%
—
—
cases:0.00%
controls:0.06%
cases:1.54%
controls:0.63%
cases:4.29%
controls:2.21%
31
195
938
9473
15
51
955
9623
7
7
963
9667
—
0
6
965
9635
14
59
896
9276
31
169
691
7464
androstanolone
G03BB02 [21602513]
1.2e+00
1.5e+00
—
—
—
1.3e+00
1.4e+00
cases:1.55%
controls:0.49%
cases:1.24%
controls:0.29%
—
—
—
—
—
—
cases:1.10%
controls:0.31%
cases:1.52%
controls:0.37%
15
47
954
9621
12
28
958
9646
—
—
—
10
29
900
9306
11
28
711
7605
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
7.3e-01
2.0e+00
—
—
—
2.0e+00
—
cases:0.52%
controls:0.25%
cases:0.62%
controls:0.08%
—
—
—
—
—
—
cases:0.66%
controls:0.09%
—
—
5
24
964
9644
6
8
964
9666
—
—
—
6
8
904
9327
—
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
8.2e-02
4.8e-01
6.5e-01
2.9e+00
5.9e-01
7.1e-02
4.9e-02
cases:34.67%
controls:32.84%
cases:27.32%
controls:18.81%
cases:4.33%
controls:2.31%
cases:1.13%
controls:0.06%
cases:3.94%
controls:2.23%
cases:19.89%
controls:18.79%
cases:42.52%
controls:41.32%
336
3175
633
6493
265
1820
705
7854
42
223
928
9451
11
6
959
9668
38
215
927
9426
181
1754
729
7581
307
3154
415
4479
pH of Urine
2756-5 [3015736]
1.0e-01
6.1e-01
1.4e+00
—
1.5e+00
4.9e-01
6.6e-02
cases:10.01%
controls:9.12%
cases:8.04%
controls:4.53%
cases:2.99%
controls:0.76%
—
—
cases:2.69%
controls:0.59%
cases:7.80%
controls:4.94%
cases:14.40%
controls:13.61%
97
882
872
8786
78
438
892
9236
29
74
941
9600
—
26
57
939
9584
71
461
839
8874
104
1039
618
6594
enoxaparin; parenteral
B01AB05 [21600976]
4.4e-01
5.6e-01
1.2e+00
—
1.5e+00
1.3e+00
7.6e-01
cases:8.46%
controls:5.61%
cases:2.89%
controls:1.66%
cases:1.03%
controls:0.30%
—
—
cases:1.14%
controls:0.25%
cases:4.95%
controls:1.47%
cases:10.11%
controls:4.99%
82
542
887
9126
28
161
942
9513
10
29
960
9645
—
11
24
954
9617
45
137
865
9198
73
381
649
7252
Neutrophils [#/volume] in Blood
26499-4 [3017732]
2.1e-01
1.1e+00
2.3e+00
—
1.2e+00
4.2e-01
6.0e-01
cases:1.55%
controls:1.26%
cases:2.16%
controls:0.74%
cases:0.72%
controls:0.07%
—
—
cases:0.52%
controls:0.16%
cases:1.43%
controls:0.94%
cases:5.68%
controls:3.21%
15
122
954
9546
21
72
949
9602
7
7
963
9667
—
5
15
960
9626
13
88
897
9247
41
245
681
7388
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
4.5e-01
8.8e-01
1.5e+00
—
1.6e+00
6.5e-01
1.8e-01
cases:3.10%
controls:2.00%
cases:2.89%
controls:1.22%
cases:1.13%
controls:0.26%
—
—
cases:1.04%
controls:0.21%
cases:1.98%
controls:1.04%
cases:2.63%
controls:2.21%
30
193
939
9475
28
118
942
9556
11
25
959
9649
—
10
20
955
9621
18
97
892
9238
19
169
703
7464
One hour or less
ZXE00 [2001311394]
6.9e-01
9.3e-01
7.3e-01
1.0e+50
1.4e+00
1.5e+00
8.6e-01
cases:12.90%
controls:6.91%
cases:3.51%
controls:1.42%
cases:0.52%
controls:0.25%
cases:0.72%
controls:0.00%
cases:0.73%
controls:0.18%
cases:4.84%
controls:1.16%
cases:8.45%
controls:3.77%
125
668
844
9000
34
137
936
9537
5
24
965
9650
7
0
963
9674
7
17
958
9624
44
108
866
9227
61
288
661
7345
ABO and Rh group [Type] in Blood
882-1 [3003694]
-3.2e-02
9.1e-01
1.6e+00
1.0e+50
3.0e+00
5.0e-01
4.7e-01
cases:5.06%
controls:5.21%
cases:3.71%
controls:1.53%
cases:0.72%
controls:0.14%
cases:1.75%
controls:0.00%
cases:2.07%
controls:0.10%
cases:2.42%
controls:1.48%
cases:8.03%
controls:5.19%
49
504
920
9164
36
148
934
9526
7
14
963
9660
17
0
953
9674
20
10
945
9631
22
138
888
9197
58
396
664
7237
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
8.8e-01
2.0e+00
—
1.0e+50
—
—
1.9e+00
cases:1.75%
controls:0.73%
cases:0.62%
controls:0.08%
—
—
cases:0.52%
controls:0.00%
—
—
—
—
cases:2.35%
controls:0.37%
17
71
952
9597
6
8
964
9666
—
5
0
965
9674
—
—
17
28
705
7605
Sedation and analgesia
WX002 [2001310758]
6.6e-01
9.7e-01
-1.0e+50
—
—
1.0e+00
1.2e+00
cases:6.19%
controls:3.30%
cases:1.96%
controls:0.75%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.76%
controls:0.63%
cases:6.37%
controls:2.07%
60
319
909
9349
19
73
951
9601
0
11
970
9663
—
—
16
59
894
9276
46
158
676
7475
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
8.5e-02
4.5e-01
—
—
—
2.5e+00
1.3e+00
cases:0.62%
controls:0.57%
cases:0.52%
controls:0.33%
—
—
—
—
—
—
cases:3.41%
controls:0.30%
cases:2.77%
controls:0.75%
6
55
963
9613
5
32
965
9642
—
—
—
31
28
879
9307
20
57
702
7576
Emergency Medicine
93 [38004510]
1.1e-01
5.1e-01
1.6e+00
—
1.1e+00
5.6e-01
2.3e-01
cases:16.82%
controls:15.38%
cases:12.99%
controls:8.26%
cases:4.85%
controls:0.99%
—
—
cases:3.42%
controls:1.20%
cases:15.05%
controls:9.20%
cases:26.87%
controls:22.53%
163
1487
806
8181
126
799
844
8875
47
96
923
9578
—
33
116
932
9525
137
859
773
8476
194
1720
528
5913
androstanolone
A14AA01 [21600917]
1.1e+00
1.3e+00
—
—
—
1.2e+00
1.3e+00
cases:1.55%
controls:0.54%
cases:1.34%
controls:0.35%
—
—
—
—
—
—
cases:1.10%
controls:0.34%
cases:1.52%
controls:0.42%
15
52
954
9616
13
34
957
9640
—
—
—
10
32
900
9303
11
32
711
7601
Cardiology
6 [38004451]
2.3e-01
3.7e-01
9.8e-01
—
1.5e+00
7.9e-01
4.2e-01
cases:14.96%
controls:12.23%
cases:8.25%
controls:5.85%
cases:2.47%
controls:0.94%
—
—
cases:3.42%
controls:0.81%
cases:11.21%
controls:5.41%
cases:17.87%
controls:12.49%
145
1182
824
8486
80
566
890
9108
24
91
946
9583
—
33
78
932
9563
102
505
808
8830
129
953
593
6680
Hemodialysis
TK800 [2001305768]
—
—
—
—
—
1.7e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.16%
cases:1.11%
controls:0.17%
—
—
—
—
—
8
15
902
9320
8
13
714
7620
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
4.1e-01
8.7e-01
—
—
—
2.3e+00
1.3e+00
cases:1.24%
controls:0.83%
cases:0.52%
controls:0.22%
—
—
—
—
—
—
cases:1.32%
controls:0.14%
cases:1.94%
controls:0.52%
12
80
957
9588
5
21
965
9653
—
—
—
12
13
898
9322
14
40
708
7593
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
5.9e-01
6.8e-01
1.1e+00
—
2.0e+00
9.4e-01
3.9e-01
cases:5.78%
controls:3.28%
cases:2.68%
controls:1.37%
cases:0.62%
controls:0.22%
—
—
cases:1.35%
controls:0.18%
cases:3.41%
controls:1.36%
cases:5.12%
controls:3.52%
56
317
913
9351
26
133
944
9541
6
21
964
9653
—
13
17
952
9624
31
127
879
9208
37
269
685
7364
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
6.2e-01
9.4e-01
—
—
1.5e+00
1.2e+00
8.6e-01
cases:3.92%
controls:2.14%
cases:1.96%
controls:0.78%
—
—
—
—
cases:0.52%
controls:0.11%
cases:2.86%
controls:0.92%
cases:5.54%
controls:2.42%
38
207
931
9461
19
75
951
9599
—
—
5
11
960
9630
26
86
884
9249
40
185
682
7448
Dyspnoea
R06.0 [45558449]
4.9e-01
9.7e-01
2.1e+00
1.0e+50
—
3.0e-01
3.7e-01
cases:6.09%
controls:3.84%
cases:3.20%
controls:1.23%
cases:0.93%
controls:0.11%
cases:0.52%
controls:0.00%
—
—
cases:1.87%
controls:1.39%
cases:6.93%
controls:4.90%
59
371
910
9297
31
119
939
9555
9
11
961
9663
5
0
965
9674
—
17
130
893
9205
50
374
672
7259
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
5.6e-01
7.2e-01
2.3e+00
—
—
1.2e+00
5.6e-01
cases:2.68%
controls:1.55%
cases:1.65%
controls:0.81%
cases:0.82%
controls:0.08%
—
—
—
—
cases:2.53%
controls:0.75%
cases:3.19%
controls:1.85%
26
150
943
9518
16
78
954
9596
8
8
962
9666
—
—
23
70
887
9265
23
141
699
7492
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
-2.2e-01
7.5e-01
1.9e+00
—
2.3e+00
1.2e+00
3.7e-01
cases:1.44%
controls:1.80%
cases:1.13%
controls:0.54%
cases:0.62%
controls:0.09%
—
—
cases:0.62%
controls:0.06%
cases:1.76%
controls:0.52%
cases:2.77%
controls:1.93%
14
174
955
9494
11
52
959
9622
6
9
964
9665
—
6
6
959
9635
16
49
894
9286
20
147
702
7486
Extensive abdominal CT
JN3BD [2001305556]
4.8e-01
1.9e+00
—
—
—
1.6e+00
4.2e-01
cases:2.06%
controls:1.29%
cases:1.24%
controls:0.20%
—
—
—
—
—
—
cases:0.88%
controls:0.17%
cases:1.39%
controls:0.92%
20
125
949
9543
12
19
958
9655
—
—
—
8
16
902
9319
10
70
712
7563
Medical Oncology
90 [38004507]
2.3e-01
2.2e-01
-5.7e-02
2.7e+00
7.8e-01
7.7e-01
5.0e-01
cases:5.47%
controls:4.41%
cases:3.61%
controls:2.93%
cases:0.93%
controls:0.98%
cases:0.93%
controls:0.06%
cases:2.07%
controls:0.96%
cases:5.93%
controls:2.83%
cases:7.20%
controls:4.51%
53
426
916
9242
35
283
935
9391
9
95
961
9579
9
6
961
9668
20
93
945
9548
54
264
856
9071
52
344
670
7289
Hypothyroidism, unspecified
E03.9 [45537945]
3.6e-01
7.8e-01
—
1.0e+50
1.7e+00
1.2e+00
6.3e-01
cases:2.89%
controls:2.04%
cases:1.96%
controls:0.91%
—
—
cases:1.03%
controls:0.00%
cases:1.04%
controls:0.20%
cases:2.97%
controls:0.93%
cases:5.26%
controls:2.87%
28
197
941
9471
19
88
951
9586
—
10
0
960
9674
10
19
955
9622
27
87
883
9248
38
219
684
7414
Pharmacy visit
OMOP4822462 [581458]
2.3e-01
5.9e-01
4.9e-01
1.0e+00
5.3e-01
8.1e-01
5.1e-01
cases:93.81%
controls:92.30%
cases:91.13%
controls:85.02%
cases:60.93%
controls:48.97%
cases:6.29%
controls:2.32%
cases:62.59%
controls:49.53%
cases:92.97%
controls:85.48%
cases:96.54%
controls:94.34%
909
8924
60
744
884
8225
86
1449
591
4737
379
4937
61
224
909
9450
604
4775
361
4866
846
7980
64
1355
697
7201
25
432
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
9.9e-01
1.1e+00
—
—
—
1.3e+00
1.0e+00
cases:2.06%
controls:0.78%
cases:1.55%
controls:0.51%
—
—
—
—
—
—
cases:1.87%
controls:0.50%
cases:1.80%
controls:0.66%
20
75
949
9593
15
49
955
9625
—
—
—
17
47
893
9288
13
50
709
7583
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
—
—
—
—
—
1.8e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.17%
cases:1.11%
controls:0.21%
—
—
—
—
—
9
16
901
9319
8
16
714
7617
General Practice
1 [38004446]
2.0e-01
4.5e-01
1.1e+00
—
1.5e+00
3.7e-01
3.7e-01
cases:15.89%
controls:13.42%
cases:7.94%
controls:5.21%
cases:2.58%
controls:0.86%
—
—
cases:3.21%
controls:0.76%
cases:8.24%
controls:5.83%
cases:21.19%
controls:15.62%
154
1297
815
8371
77
504
893
9170
25
83
945
9591
—
31
73
934
9568
75
544
835
8791
153
1192
569
6441
valaciclovir; oral
J05AB11 [21603137]
1.5e-01
1.1e+00
1.8e+00
—
1.7e+00
1.5e+00
8.1e-01
cases:2.17%
controls:1.87%
cases:1.75%
controls:0.59%
cases:0.52%
controls:0.08%
—
—
cases:0.62%
controls:0.11%
cases:3.30%
controls:0.77%
cases:4.71%
controls:2.16%
21
181
948
9487
17
57
953
9617
5
8
965
9666
—
6
11
959
9630
30
72
880
9263
34
165
688
7468
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
5.4e-01
8.4e-01
1.8e+00
1.0e+50
1.6e+00
8.3e-01
6.2e-01
cases:2.48%
controls:1.46%
cases:1.44%
controls:0.63%
cases:0.72%
controls:0.12%
cases:0.82%
controls:0.00%
cases:0.83%
controls:0.17%
cases:2.09%
controls:0.92%
cases:4.57%
controls:2.52%
24
141
945
9527
14
61
956
9613
7
12
963
9662
8
0
962
9674
8
16
957
9625
19
86
891
9249
33
192
689
7441
tinzaparin; parenteral
B01AB10 [21600981]
5.0e-01
3.4e-01
—
—
2.0e+00
1.4e+00
4.1e-01
cases:1.75%
controls:1.08%
cases:0.82%
controls:0.59%
—
—
—
—
cases:0.83%
controls:0.11%
cases:2.53%
controls:0.65%
cases:2.35%
controls:1.57%
17
104
952
9564
8
57
962
9617
—
—
8
11
957
9630
23
61
887
9274
17
120
705
7513
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
2.7e-01
6.7e-01
1.4e+00
—
1.0e+00
7.9e-01
4.4e-01
cases:11.66%
controls:9.16%
cases:9.48%
controls:5.10%
cases:2.37%
controls:0.58%
—
—
cases:1.35%
controls:0.50%
cases:10.22%
controls:4.91%
cases:19.81%
controls:13.69%
113
886
856
8782
92
493
878
9181
23
56
947
9618
—
13
48
952
9593
93
458
817
8877
143
1045
579
6588
Physiotherapist
Z3226 [2001311560]
6.3e-01
9.6e-01
—
—
—
1.6e+00
1.1e+00
cases:4.44%
controls:2.41%
cases:1.24%
controls:0.48%
—
—
—
—
—
—
cases:2.53%
controls:0.54%
cases:4.71%
controls:1.60%
43
233
926
9435
12
46
958
9628
—
—
—
23
50
887
9285
34
122
688
7511
Pulmonary Disease
29 [38004472]
2.6e-01
7.3e-01
1.3e+00
—
6.4e-01
7.3e-01
5.8e-01
cases:12.49%
controls:9.88%
cases:9.69%
controls:4.92%
cases:3.30%
controls:0.95%
—
—
cases:1.66%
controls:0.88%
cases:10.33%
controls:5.27%
cases:16.34%
controls:9.84%
121
955
848
8713
94
476
876
9198
32
92
938
9582
—
16
85
949
9556
94
492
816
8843
118
751
604
6882
potassium chloride; oral
A12BA01 [21600877]
2.9e-01
6.1e-01
—
—
1.7e+00
7.7e-01
7.7e-01
cases:2.37%
controls:1.78%
cases:1.96%
controls:1.08%
—
—
—
—
cases:1.14%
controls:0.21%
cases:2.86%
controls:1.34%
cases:5.96%
controls:2.86%
23
172
946
9496
19
104
951
9570
—
—
11
20
954
9621
26
125
884
9210
43
218
679
7415

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
255
152
21.96
318.44
1.5
1.2
52.48
37.46
u/l
0.40
225
135
245
71
44.95
307.65
1.2
1.3
—
—
—
0
0
381
122
48.95
307.65
1.8
1.8
—
—
—
0
0
342
79
64.28
307.65
1.3
1.4
—
—
—
0
0
530
1091
8.94
277.82
4.3
2.6
1.86
1.82
%
0.44
496
983
460
838
9.11
268.23
4.5
2.7
76.80
70.13
e9/l
2.17
288
631
773
3123
6.90
181.33
15.1
6.0
—
—
—
0
0
468
1372
5.42
155.16
3.6
2.6
24.86
22.45
%
2.52
452
1284
473
1482
5.05
142.61
3.6
2.5
2.30
2.30
g/l
0.04
453
1379
479
1599
4.73
131.31
3.7
2.6
14.07
12.75
umol/l
2.87
460
1490
839
4350
5.99
127.05
16.2
6.2
2.79
2.86
%
0.35
808
4066
840
4364
5.99
126.74
16.4
6.3
9.41
8.93
%
1.92
810
4084
837
4356
5.90
125.42
16.4
6.3
0.79
0.68
%
5.63
807
4067
842
4441
5.89
122.96
16.4
6.3
28.44
27.21
%
2.10
816
4204
227
427
6.53
120.44
2.9
1.8
1.21
1.54
g/l
5.02
207
378
820
4368
5.29
114.42
16.0
6.1
56.23
57.69
%
2.54
800
4166
203
374
6.51
109.46
5.4
2.5
2.97
2.99
g/l
0.08
195
349
861
4878
5.64
107.82
17.0
6.4
0.22
0.19
e9/l
1.37
752
4255
846
4730
5.39
107.72
15.3
6.1
0.66
0.59
e9/l
3.08
715
4049
846
4742
5.37
107.02
15.3
6.1
0.05
0.04
e9/l
10.19
715
4061
849
4812
5.33
104.73
15.6
6.2
2.34
1.91
e9/l
1.27
746
4230
205
400
6.15
103.97
5.3
2.5
6.75
7.43
g/l
5.86
197
375
205
400
6.15
103.97
5.3
2.5
3.68
3.71
g/l
0.08
197
375
205
400
6.15
103.97
5.3
2.5
4.04
4.22
g/l
1.68
196
375
189
344
6.50
102.88
5.2
2.5
10.75
10.65
g/l
0.08
180
317
177
330
6.27
93.67
5.9
3.8
52.91
51.40
mg/l
0.04
162
290
177
330
6.27
93.67
5.9
3.8
60.56
65.81
mg/l
0.10
162
288
257
670
4.78
92.97
4.6
2.6
—
—
—
0
0
872
5275
5.23
92.66
23.9
9.2
4.58
4.16
e9/l
2.40
759
4583
166
294
6.54
92.48
6.0
3.6
4.67
2.55
ratio
0.45
84
170
540
2405
3.61
90.42
4.4
2.8
351.80
346.92
umol/l
0.45
507
2111
740
4044
3.94
89.53
23.7
11.3
0.02
0.00
e9/l
1.28
570
3308
282
821
4.35
88.07
4.6
2.9
66.55
66.72
g/l
0.13
268
767
508
2340
3.31
77.50
8.3
4.1
85.87
89.67
%
2.69
496
2299
82
77
11.48
76.71
1.2
1.1
—
—
—
0
0
130
220
6.62
75.28
1.9
1.7
—
—
—
0
0
218
585
4.46
74.89
2.5
1.7
1.61
1.45
g/l
0.28
204
540
247
736
4.10
73.62
3.2
2.8
10.55
11.01
g/l
0.59
234
677
554
2850
3.04
67.03
8.2
4.1
7.39
7.40
ph
1.29
386
2074
499
2456
3.00
64.87
3.2
2.2
3.07
2.89
mg/l
0.49
441
2103
776
4907
3.35
63.43
11.8
6.5
11.58
11.68
umol/l
0.11
764
4702
211
648
3.84
59.33
1.4
1.4
—
—
—
0
0
56
43
13.71
59.20
2.1
1.7
—
—
—
0
0
284
1059
3.32
59.13
5.4
2.9
6.25
8.19
umol/l
2.05
254
951
694
4218
2.97
58.86
5.5
3.0
163.62
131.60
ug/l
0.93
661
3924
683
4159
2.90
56.91
9.7
5.1
35.78
35.53
g/l
0.55
661
3928
318
1308
3.07
55.61
8.3
5.8
1.05
1.03
mmol/l
0.40
307
1212
516
2779
2.72
53.71
14.0
6.0
—
—
—
0
0
683
4277
2.77
51.78
10.9
6.6
1.22
1.21
mmol/l
1.63
656
3956
72
96
7.99
51.47
2.4
2.1
—
—
—
0
0
88
148
6.41
50.88
1.4
1.4
147.92
154.84
au/ml
0.19
38
41
253
972
3.12
49.17
1.7
1.6
—
—
—
0
0
128
322
4.40
46.85
3.3
2.0
20.98
21.06
s
0.07
122
290
89
164
5.85
46.83
1.3
1.4
—
—
—
0
0
79
130
6.50
46.60
3.4
2.3
0.90
0.91
%
0.05
53
96
714
4753
2.63
44.74
11.9
7.3
1.21
1.21
mmol/l
0.33
623
4125
223
838
3.12
44.66
8.2
4.8
0.99
0.91
%
0.14
102
257
280
1205
2.82
43.76
1.7
1.6
—
—
—
0
0
476
2654
2.47
43.52
4.5
3.3
0.66
0.43
e6/l
0.92
346
1975
92
189
5.25
42.95
1.3
1.2
—
—
—
0
0
215
814
3.07
42.32
7.7
4.4
0.77
0.59
%
0.56
102
246
68
106
6.80
42.20
2.1
2.5
0.83
1.13
g/24h
0.58
56
64
211
815
3.00
39.92
8.6
5.0
0.57
0.11
%
1.45
93
202
321
1541
2.57
39.84
4.0
3.2
1.86
2.36
e6/l
0.61
154
784
904
6993
3.38
38.96
18.2
8.2
81.73
79.11
u/l
1.20
883
6625
303
1429
2.59
38.89
1.8
1.8
—
—
—
0
0
562
3490
2.34
38.85
5.8
4.1
99.72
104.02
e6/l
0.05
396
2497
219
877
2.90
38.71
2.8
2.4
35.98
35.48
u/l
0.05
188
734
358
1836
2.46
38.31
2.2
1.5
2.52
2.50
g/l
0.06
248
1122
205
806
2.93
37.38
8.1
4.8
0.08
0.08
%
0.03
86
224
512
3094
2.30
37.26
4.5
3.4
45.73
84.38
e6/l
0.80
382
2400
48
61
8.20
35.59
1.9
1.6
36.76
37.99
%
0.18
48
61
301
1475
2.47
35.11
3.6
2.0
30.16
29.54
s
1.09
293
1433
74
153
5.13
34.20
3.6
3.2
4.96
4.27
e9/l
0.83
74
153
465
2811
2.19
32.51
2.3
1.7
20.10
20.16
nmol/l
0.03
426
2361
312
1623
2.32
31.27
4.8
3.3
0.81
0.82
mmol/l
0.58
303
1539
620
4236
2.16
31.17
3.0
2.2
90.60
95.45
pmol/l
2.09
390
2215
365
2035
2.23
30.90
2.5
1.7
1.41
1.20
mg/l
0.67
307
1585
192
801
2.72
30.88
1.5
1.4
—
—
—
0
0
81
198
4.35
30.52
4.6
3.1
57.32
58.61
%
0.30
81
198
75
173
4.60
30.40
1.4
1.3
209.91
275.06
u/ml
0.98
45
95
314
1665
2.27
29.87
3.9
3.0
1.27
1.16
e6/l
0.08
153
916
333
1820
2.23
29.34
5.2
4.1
177.32
527.70
ng/l
2.48
279
1439
261
1294
2.36
28.95
1.5
1.3
333.95
494.77
titre
1.24
43
298
486
3091
2.08
28.73
5.3
3.3
33.42
33.43
u/l
0.00
471
2924
330
1817
2.20
28.39
3.5
3.0
524.66
526.51
mosm/kgh2o
0.05
288
1604
90
253
3.80
28.01
1.3
1.3
—
—
—
0
0
195
858
2.57
27.98
11.8
9.0
—
—
—
0
0
45
79
5.91
24.77
1.2
1.2
—
—
—
0
0
345
2019
2.07
24.70
9.8
4.9
—
—
—
0
0
332
1920
2.08
24.52
3.5
3.0
2.45
2.45
mmol/l
0.07
303
1729
46
86
5.55
23.71
2.3
2.4
57.74
57.89
iu/ml
—
5
10
27
5
55.37
23.14
1.1
1.0
—
—
—
0
0
487
3282
1.92
22.71
4.5
3.5
2.35
2.36
mmol/l
0.96
453
2977
81
248
3.46
22.15
3.6
3.2
4.22
2.19
index
0.36
55
133
287
1627
2.06
22.00
1.9
1.7
1091.83
1180.63
nmol/l
0.76
214
1235
160
715
2.47
21.89
4.8
3.8
—
—
—
0
0
651
4872
1.91
21.51
4.3
4.1
0.00
0.01
estimate
1.46
171
954
33
49
6.92
21.33
2.1
2.3
299.82
201.57
e6/l
0.61
28
42
707
5453
1.94
21.12
9.5
5.2
6.74
6.71
mmol/l
0.15
686
5206
58
146
4.15
20.99
1.2
1.1
—
—
—
0
0
181
870
2.31
20.97
10.8
7.4
10.38
9.89
mmol/l
0.37
174
834
57
142
4.19
20.91
6.5
3.6
1.07
1.35
%
0.28
45
133
644
4832
1.89
20.77
4.2
4.1
7.48
4.82
estimate
0.13
180
1020
639
4785
1.88
20.71
4.2
4.0
0.00
0.00
estimate
0.50
176
997
343
2138
1.91
19.61
3.3
2.7
4.59
5.29
e6/l
0.55
309
1959
36
65
5.70
19.25
2.0
2.0
1449.87
1209.02
e6/l
0.53
30
56
863
7235
2.18
19.17
49.0
20.3
14.76
13.65
%
36.38
857
7144
443
3023
1.82
18.78
5.7
2.4
—
—
—
0
0
400
2661
1.82
18.33
7.7
4.3
—
—
—
0
0
80
276
3.06
17.98
2.4
1.7
0.25
0.24
g/l
0.50
73
266
30
49
6.28
17.73
2.0
2.1
698.62
521.95
e6/l
0.69
24
38
95
364
2.77
17.66
1.3
1.2
—
—
—
0
0
39
84
4.79
17.16
2.1
2.2
1157.88
1120.58
mg
0.03
39
84
213
1175
2.02
17.11
4.7
3.2
4.72
5.04
e9/l
0.23
192
1010
80
285
2.96
16.99
2.4
1.7
1.22
1.18
g/l
0.59
74
273
32
59
5.57
16.74
1.6
3.0
43.57
40.94
%
—
7
32
55
158
3.62
16.55
1.2
1.1
—
—
—
0
0
731
5940
1.79
15.74
6.0
4.8
489.83
2031.33
e6/l
—
6
99
574
4367
1.71
15.58
22.0
14.9
1.28
1.26
inr
0.47
483
3644
197
1098
1.98
15.23
2.3
1.7
—
—
—
0
0
416
2938
1.70
14.61
2.5
2.2
198.60
223.56
u/l
0.19
398
2801
174
943
2.02
14.51
3.1
2.3
0.21
0.21
g/l
0.19
162
882
220
1298
1.88
14.27
1.3
1.2
—
—
—
0
0
37
89
4.27
14.22
1.1
1.2
—
—
—
0
0
175
964
1.98
13.90
5.6
3.6
0.91
1.92
mmol/l
2.19
151
827
513
3871
1.65
13.68
3.5
3.6
6.03
6.23
ph
3.32
221
2196
43
122
3.63
13.20
1.5
1.5
—
—
—
0
0
43
122
3.63
13.20
1.5
1.5
—
—
—
0
0
43
122
3.63
13.20
1.5
1.5
—
—
—
0
0
43
122
3.63
13.20
1.5
1.5
—
—
—
0
0
178
1003
1.94
13.20
5.6
3.6
7.37
7.38
ph
1.90
88
574
33
77
4.39
13.19
1.2
1.1
270.00
186.15
titre
—
6
13
177
1000
1.93
13.01
5.7
3.5
5.80
5.79
kpa
0.03
171
972
19
10
19.33
12.94
1.4
1.2
—
—
—
0
0
956
8667
2.42
12.71
34.8
16.5
23.73
24.69
mg/l
0.42
861
7184
540
4185
1.61
12.49
3.3
2.5
79.19
77.41
nmol/l
0.73
498
3752
162
901
1.95
12.44
2.5
2.1
361.52
381.79
nmol/l
0.67
155
844
43
130
3.41
12.01
1.6
1.2
5.15
5.15
u/ml
0.00
27
52
476
3615
1.59
11.74
2.6
2.2
—
—
—
0
0
190
1135
1.83
11.66
9.8
8.3
-0.09
0.98
mmol/l
2.68
171
936
191
1143
1.82
11.65
9.8
8.3
7.42
7.41
ph
0.70
81
650
546
4290
1.58
11.57
5.9
2.8
—
—
estimate
—
0
0
25
52
4.90
11.47
2.8
1.3
11.14
6.60
ug/l
1.20
25
46
140
761
1.97
11.46
5.3
3.9
105.83
90.05
ng/l
0.94
128
670
223
1406
1.75
11.38
2.5
2.1
—
—
—
0
0
23
26
9.02
11.29
1.2
1.1
—
—
—
0
0
53
189
2.90
11.27
5.7
3.4
—
—
—
0
0
34
92
3.79
11.19
1.7
1.9
9.46
10.38
%
0.48
34
92
34
92
3.79
11.19
2.8
2.3
—
—
—
0
0
20
20
10.17
10.53
2.4
2.1
1.52
0.24
e9/l
—
14
7
493
3840
1.54
10.47
2.3
2.0
1.46
1.35
mmol/l
2.15
405
3221
22
27
8.30
10.35
1.4
1.6
—
—
—
0
0
120
656
1.94
9.62
13.0
10.0
93.65
93.98
%
0.23
120
651
20
40
5.08
9.59
1.2
1.4
58.13
69.17
mg/l
0.35
15
30
17
15
11.50
9.58
1.1
1.0
—
—
—
0
0
394
2971
1.53
9.42
3.9
3.2
2173.32
1297.71
ng/l
2.03
327
2563
35
111
3.23
9.11
1.3
1.2
—
—
—
0
0
81
391
2.16
9.11
2.1
2.0
13.96
7.87
iu/ml
0.57
12
90
45
167
2.77
8.93
6.6
3.7
2.65
2.53
mmol/l
0.08
31
114
128
733
1.85
8.90
3.4
3.0
230.68
211.24
ng/l
0.20
119
678
172
1089
1.70
8.46
1.5
1.4
—
—
—
0
0
17
20
8.62
8.32
1.0
1.0
—
—
—
0
0
16
17
9.54
8.29
1.1
1.4
—
—
—
0
0
18
25
7.31
7.98
1.0
1.0
—
—
—
0
0
126
746
1.78
7.84
5.2
3.8
1.22
1.23
mmol/l
0.19
103
644
52
222
2.41
7.81
1.3
1.2
—
—
—
0
0
30
97
3.16
7.60
7.6
3.3
54.63
56.93
%
0.15
19
89
184
1222
1.62
7.47
1.4
1.3
—
—
—
0
0
32
109
3.00
7.44
1.5
1.3
0.18
0.19
nmol/l
0.10
25
83
177
1166
1.63
7.42
1.6
1.5
—
—
—
0
0
31
104
3.04
7.40
1.2
1.1
—
—
—
0
0
175
1152
1.63
7.36
2.7
2.4
141.14
119.26
ug/g
0.29
148
930
23
64
3.65
7.33
1.2
1.2
—
—
—
0
0
687
5961
1.46
7.29
4.8
3.4
57.95
50.19
u/l
1.19
659
5606
27
84
3.27
7.28
1.4
1.3
—
—
—
0
0
413
3275
1.44
7.14
5.0
4.1
18.49
8.96
mg/mmol
2.15
265
2045
119
712
1.76
7.14
1.3
1.2
—
—
—
0
0
21
56
3.81
7.10
4.4
3.5
0.81
0.91
index
0.29
21
56
328
2493
1.46
7.10
1.5
1.4
—
—
—
0
0
93
517
1.88
7.09
3.0
3.7
4.36
4.46
pmol/l
0.43
85
460
280
2068
1.49
6.99
1.4
1.3
2.04
1.57
u/ml
0.20
52
571
15
20
7.59
6.91
1.2
1.1
—
—
—
0
0
367
2862
1.44
6.89
3.7
3.2
—
—
—
0
0
889
8175
1.64
6.84
6.5
5.4
1.94
1.97
mu/l
0.21
838
7527
38
149
2.61
6.84
1.7
1.7
0.92
0.82
g/l
0.16
32
116
336
2588
1.44
6.71
4.1
3.4
0.00
0.01
estimate
1.68
146
791
955
8969
1.88
6.63
36.5
19.6
139.46
139.69
mmol/l
2.06
943
8803
23
69
3.39
6.58
1.2
1.2
—
—
—
0
0
15
22
6.90
6.53
1.1
2.2
—
—
—
0
0
132
833
1.67
6.53
3.8
3.0
4.45
4.51
kpa
0.12
126
809
955
8983
1.86
6.39
39.2
19.8
3.98
3.98
mmol/l
0.04
941
8799
26
87
3.04
6.26
4.7
3.4
16.43
11.21
index
1.42
21
56
25
82
3.10
6.22
1.4
1.3
0.32
0.41
g/l
0.68
20
55
25
82
3.10
6.22
1.4
1.3
3.20
2.83
g/l
0.28
20
55
25
82
3.10
6.22
1.4
1.3
9.40
7.26
g/l
0.51
20
56
417
3380
1.39
6.10
4.6
3.4
7.49
7.62
mmol/l
0.21
341
2854
83
473
1.82
5.87
1.3
1.2
—
—
—
0
0
32
125
2.61
5.83
1.5
1.3
0.84
0.64
nmol/l
0.85
32
119
768
6917
1.43
5.83
5.1
4.4
14.85
14.85
pmol/l
0.01
704
6343
32
126
2.59
5.75
1.6
1.3
376.67
294.19
pmol/l
0.45
27
111
397
3217
1.38
5.72
4.4
3.5
113.80
49.28
mg/l
2.28
277
2069
28
104
2.74
5.63
1.6
1.3
—
—
—
0
0
21
66
3.23
5.61
1.6
2.5
26.25
31.24
mg/l
0.26
16
50
48
231
2.13
5.52
1.6
1.4
9.33
9.32
u/l
0.00
32
186
40
184
2.22
5.15
1.6
1.3
—
—
—
0
0
893
8338
1.53
5.12
7.9
6.7
39.38
39.45
mmol/mol
0.07
845
7807
26
99
2.67
5.01
1.3
1.2
—
—
—
0
0
63
347
1.87
4.99
1.6
1.4
22.31
26.12
iu/l
0.51
49
301
963
9167
1.77
4.96
25.3
12.4
26.58
26.09
u/l
0.45
943
8904
15
34
4.46
4.75
3.8
3.1
0.61
0.61
mmol/l
0.02
15
34
59
324
1.87
4.73
1.7
1.6
36.72
9.56
u/ml
1.04
12
69
68
394
1.78
4.60
1.4
1.7
0.42
0.35
mg/l
0.19
19
183
28
118
2.41
4.43
1.5
1.4
—
—
—
0
0
143
1011
1.48
4.31
3.1
4.4
4.82
22.34
ug/l
1.39
118
832
54
301
1.84
4.16
1.4
1.5
275.03
280.95
ug/g
0.06
32
178
11
21
5.28
4.15
1.4
1.7
90.09
65.24
nmol/24h
0.40
11
21
966
9260
1.69
4.08
43.1
21.6
82.60
78.51
umol/l
2.76
957
9158
70
426
1.69
4.01
1.4
1.3
—
—
—
0
0
7
7
10.06
4.01
2.1
4.4
—
—
—
0
0
25
105
2.42
4.00
1.4
1.3
—
—
nmol/l
—
0
0
357
2970
1.31
3.98
3.4
2.6
54.05
87.53
u/l
0.67
333
2767
129
910
1.48
3.94
1.7
1.5
—
—
—
0
0
90
597
1.56
3.67
1.3
1.2
195.42
143.46
u/ml
0.52
36
240
10
22
4.58
3.43
1.1
1.3
26.80
26.73
s
—
10
22
90
607
1.53
3.42
1.5
1.3
156.87
240.05
u/ml
0.65
79
558
11
27
4.11
3.40
5.3
3.4
—
—
—
0
0
18
70
2.60
3.39
1.8
1.2
—
—
—
0
0
39
211
1.88
3.35
1.6
1.3
4.24
59.37
e6/l
1.11
29
153
14
48
2.94
3.31
1.2
1.0
—
—
—
0
0
39
212
1.87
3.30
1.6
1.3
166.47
663.02
e6/l
0.43
30
160
15
54
2.80
3.26
1.7
1.8
—
—
—
0
0
13
43
3.05
3.26
1.4
1.4
144.00
162.67
mmol/24h
0.39
13
43
34
179
1.93
3.17
1.3
1.3
54.41
61.68
mmol/l
0.46
29
148
20
85
2.38
3.16
1.3
1.0
—
—
—
0
0
29
145
2.03
3.12
1.4
1.5
30.72
31.96
g/l
0.21
24
130
6
8
7.54
3.06
1.2
1.0
0.02
0.05
u/ml
—
6
8
35
190
1.87
3.00
1.6
1.5
—
—
—
0
0
9
21
4.31
3.00
1.3
1.2
—
—
—
0
0
18
75
2.42
2.98
2.6
1.6
—
—
—
0
0
15
57
2.66
2.97
1.2
1.0
—
—
—
0
0
9
22
4.12
2.88
1.8
1.4
39.78
29.32
%
—
9
22
23
109
2.14
2.86
1.4
1.4
—
—
—
0
0
41
238
1.75
2.85
3.4
2.1
134.17
129.60
g/l
0.39
30
187
239
1960
1.29
2.84
1.8
1.8
30481773.43
36730141.91
pmol/l
0.07
187
1639
26
130
2.03
2.82
1.3
1.4
954.37
1648.98
e6/l
1.23
19
83
918
8803
1.39
2.79
7.1
6.0
2.49
2.68
mmol/l
8.34
878
8159
9
23
3.94
2.78
1.6
1.5
—
—
—
0
0
6
10
6.03
2.70
1.3
1.0
—
—
—
0
0
60
392
1.56
2.68
2.8
3.6
591.56
3807.65
u/ml
0.67
51
340
21
99
2.14
2.66
2.1
1.4
34.05
25.60
ng/l
0.43
21
99
86
608
1.45
2.65
2.4
2.5
6.83
21.70
au/ml
—
7
47
888
8488
1.33
2.62
5.8
5.3
6.02
5.98
mmol/l
0.38
826
7778
79
551
1.47
2.61
1.3
1.3
36.29
56.28
au/ml
—
7
43
7
15
4.69
2.60
1.3
1.6
—
—
—
0
0
0
70
0.00
2.59
0.0
2.8
—
8.34
—
0
70
23
114
2.04
2.57
1.4
1.4
199560.80
33972.50
e6/l
0.64
15
58
5
7
7.17
2.55
1.2
1.0
—
—
—
0
0
5
7
7.17
2.55
1.2
1.0
—
—
—
0
0
23
116
2.01
2.47
1.4
1.6
—
—
—
0
0
32
182
1.78
2.42
3.8
3.3
9.88
8.61
pmol/l
0.26
32
182
927
8940
1.37
2.38
25.0
14.8
—
—
—
0
0
210
1732
1.27
2.37
1.4
1.3
36.23
32.04
iu/ml
0.11
59
545
12
46
2.63
2.36
1.1
1.2
—
—
—
0
0
66
462
1.46
2.18
2.2
2.4
—
—
—
0
0
6
14
4.30
2.15
6.3
2.1
1.17
2.64
%
—
6
14
6
14
4.30
2.15
1.3
1.3
—
—
—
0
0
191
1579
1.26
2.11
1.3
1.3
15.81
12.37
u/ml
0.21
51
600
896
8627
1.29
2.10
6.1
5.2
1.31
1.46
mmol/l
26.32
855
7979
20
104
1.94
2.01
1.4
1.3
284.00
278.51
mosm/kgh2o
0.28
14
77
861
8262
1.26
1.99
5.1
4.4
1.43
1.29
mmol/l
5.14
817
7572
5
11
4.56
1.94
8.4
7.2
5.34
5.81
mmol/l
—
5
11
6
16
3.77
1.93
1.0
1.0
—
—
—
0
0
6
16
3.77
1.93
1.2
1.2
—
—
—
0
0
967
9432
1.41
1.91
54.5
25.0
92.48
91.24
fl
5.47
959
9335
967
9433
1.40
1.90
54.7
25.1
310.06
248.01
e9/l
28.74
947
9256
898
8672
1.28
1.87
6.3
5.3
4.27
4.60
mmol/l
17.52
866
8070
967
9435
1.40
1.87
54.5
25.0
4.44
4.48
e12/l
0.72
945
9228
967
9435
1.40
1.87
54.4
24.9
30.49
30.36
pg
0.66
959
9336
967
9435
1.40
1.87
56.0
25.6
40.01
40.29
%
0.75
959
9331
967
9436
1.40
1.86
54.6
25.1
8.06
6.75
e9/l
7.06
945
9225
967
9437
1.40
1.85
55.1
25.2
131.77
134.93
g/l
5.17
959
9338
97
748
1.33
1.84
3.8
2.4
13.37
13.39
nmol/l
0.01
91
676
403
3631
1.18
1.83
4.2
4.0
0.03
0.04
estimate
0.16
147
822
60
428
1.43
1.83
1.1
1.1
—
139.60
—
0
10
37
239
1.57
1.81
1.5
2.0
2.48
27.70
iu/l
—
10
99
8
29
2.77
1.79
2.1
1.9
—
—
—
0
0
20
111
1.82
1.69
1.6
1.5
0.35
0.33
nmol/l
0.05
15
86
24
141
1.72
1.69
2.8
2.5
—
—
—
0
0
84
646
1.33
1.65
4.5
3.7
7.41
7.42
ph
0.49
70
540
39
263
1.50
1.60
1.2
1.2
—
—
—
0
0
15
77
1.96
1.59
1.7
1.5
26.74
32.25
%
—
8
51
207
1779
1.20
1.59
3.1
3.2
0.59
0.75
ug/l
3.60
145
1171
85
659
1.32
1.58
4.5
3.7
5.25
5.16
kpa
0.40
79
634
8
33
2.44
1.54
1.6
1.5
—
—
—
0
0
5
15
3.34
1.52
1.2
1.4
—
—
—
0
0
11
51
2.17
1.51
2.3
2.4
419.83
488.72
min
—
6
36
68
883
0.75
1.46
3.7
4.3
7.33
7.35
ph
0.36
52
635
397
3626
1.15
1.45
5.0
3.9
43.35
62.47
ng/l
0.49
291
2660
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
5
16
3.13
1.44
6.6
2.4
57.60
46.87
u/l
—
5
16
53
389
1.38
1.42
3.5
2.7
—
—
—
0
0
10
199
0.50
1.41
1.9
3.8
28.44
26.06
mg/l
—
10
141
302
2709
1.16
1.40
4.5
4.1
0.01
0.01
estimate
0.02
164
932
6
23
2.62
1.37
1.2
1.4
—
—
—
0
0
21
334
0.62
1.36
3.6
4.0
1.30
1.37
mmol/l
0.23
21
326
9
42
2.15
1.34
3.6
2.9
—
—
—
0
0
78
616
1.29
1.30
1.4
1.3
—
—
—
0
0
29
194
1.51
1.28
2.2
2.1
7755.62
5507.91
u/l
—
8
76
19
115
1.66
1.25
1.4
1.9
—
—
—
0
0
6
25
2.41
1.24
8.5
4.9
45.67
49.02
%
—
6
25
18
108
1.68
1.22
1.9
1.6
63.80
59.08
%
—
10
73
19
117
1.64
1.18
1.2
1.1
9.78
2.04
eliau/ml
—
6
46
0
34
0.00
1.16
0.0
1.0
—
3.04
—
0
5
22
143
1.55
1.12
1.1
1.1
—
—
—
0
0
16
96
1.68
1.10
2.4
2.4
—
—
—
0
0
22
144
1.54
1.09
1.1
1.1
—
—
—
0
0
19
120
1.59
1.09
6.8
2.4
—
—
—
0
0
192
2163
0.86
1.09
3.9
4.3
1.02
1.02
kg/l
0.26
142
1461
23
153
1.51
1.07
1.2
1.1
2.72
1.62
u/ml
0.22
16
78
20
129
1.56
1.06
1.4
1.2
—
—
—
0
0
12
67
1.80
1.05
2.3
2.3
666.50
628.98
ml
—
6
45
13
75
1.74
1.03
1.4
1.2
383.69
371.17
nmol/l
0.08
13
64
18
272
0.66
0.98
3.9
4.0
3.84
3.90
mmol/l
0.19
18
267
20
133
1.51
0.95
1.3
1.2
—
—
—
0
0
19
125
1.53
0.94
1.1
1.0
0.10
1.82
u/ml
1.37
13
57
7
37
1.90
0.94
2.7
3.1
—
—
—
0
0
93
787
1.20
0.90
1.4
1.5
—
—
—
0
0
8
42
1.91
0.88
3.3
1.7
40.77
39.90
g/l
—
8
42
49
614
0.79
0.87
1.6
1.7
3.41
3.51
mmol/l
0.33
42
455
8
43
1.87
0.87
3.1
1.7
—
—
—
0
0
10
57
1.76
0.84
1.4
1.3
134.11
173.79
pmol/l
—
10
57
15
226
0.66
0.83
2.1
4.9
—
—
—
0
0
54
436
1.25
0.82
1.1
1.1
—
—
—
0
0
79
667
1.20
0.80
1.9
1.7
—
—
—
0
0
8
48
1.67
0.79
1.0
1.1
407.13
513.67
u/l
—
8
42
18
123
1.47
0.78
1.1
1.0
0.11
2.01
u/ml
0.91
11
42
0
28
0.00
0.76
0.0
1.3
—
0.39
—
0
7
0
28
0.00
0.76
0.0
1.2
—
138.55
—
0
20
14
91
1.55
0.75
1.0
1.0
0.78
0.64
u/ml
—
8
24
36
280
1.30
0.75
1.6
1.2
0.87
0.91
g/l
0.31
36
280
16
108
1.49
0.73
1.1
1.1
—
—
—
0
0
7
38
1.85
0.73
1.0
1.0
1339.43
1586.82
miu/ml
—
7
38
15
100
1.51
0.73
1.2
1.2
—
—
—
0
0
12
78
1.54
0.65
1.1
1.1
—
—
—
0
0
5
29
1.73
0.64
2.0
1.4
0.20
3.57
%
—
5
24
15
104
1.45
0.62
1.5
1.3
—
—
—
0
0
13
88
1.48
0.60
1.2
1.1
—
—
—
0
0
6
35
1.72
0.57
1.0
1.1
105.13
195.06
iu/ml
—
6
35
29
229
1.27
0.57
3.2
2.4
265.20
99.82
ug/min
0.41
15
139
8
55
1.46
0.56
1.9
1.3
12.50
24.43
umol/l
—
8
47
6
37
1.63
0.55
1.2
1.4
1.95
1.91
umol/l
—
6
31
15
107
1.41
0.55
1.0
1.1
1.18
7.42
u/ml
—
10
37
102
912
1.13
0.54
2.6
2.2
0.00
0.02
estimate
0.50
22
173
83
732
1.15
0.54
2.5
2.6
5.97
6.06
ph
0.41
58
500
54
464
1.17
0.50
3.0
2.2
0.00
1.90
estimate
0.50
17
132
6
41
1.47
0.50
1.8
1.3
13.67
8.83
mm/h
—
6
41
10
67
1.50
0.49
1.1
1.1
—
—
—
0
0
11
76
1.45
0.48
1.1
1.1
128.64
103.43
pmol/l
1.00
11
76
17
128
1.33
0.48
1.1
1.0
3.17
4.54
u/ml
0.22
11
58
31
257
1.21
0.43
1.8
1.6
23206.95
14214.18
e6/l
0.32
22
181
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
5.9
—
8.16
—
0
17
50
437
1.15
0.40
1.9
2.0
—
—
—
0
0
9
69
1.31
0.37
1.1
1.3
—
—
—
0
0
18
143
1.26
0.37
1.9
1.8
—
—
—
0
0
28
238
1.18
0.32
1.3
1.3
183.24
241.45
miu/ml
0.42
15
115
38
333
1.15
0.31
2.8
3.4
870.00
266.41
mg/l
1.14
24
150
77
836
0.91
0.29
2.8
2.5
0.49
0.40
e6/l
0.16
77
800
5
75
0.67
0.26
1.0
1.0
197.80
300.06
ng/l
—
5
50
0
12
0.00
0.21
0.0
1.3
—
0.44
—
0
12
0
12
0.00
0.21
0.0
2.0
—
6.82
—
0
5
8
104
0.77
0.21
3.9
2.7
—
—
—
0
0
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
18.67
—
0
6
23
203
1.14
0.19
1.8
3.7
346.70
323.58
u/ml
0.02
23
191
6
52
1.15
0.19
2.7
2.5
—
—
—
0
0
30
271
1.11
0.18
4.8
2.0
—
—
—
0
0
30
271
1.11
0.18
4.8
1.9
—
—
—
0
0
38
414
0.91
0.18
1.9
1.7
—
—
—
0
0
30
273
1.10
0.16
4.8
1.9
—
—
—
0
0
29
265
1.10
0.15
12.6
10.9
—
—
—
0
0
26
237
1.10
0.14
1.4
1.3
—
—
—
0
0
9
108
0.83
0.13
1.4
1.5
—
—
—
0
0
6
54
1.11
0.09
1.0
1.4
157.33
140.95
nmol/l
—
6
54
306
3020
1.02
0.09
5.0
5.6
2.06
2.50
ug/l
0.75
270
2708
27
253
1.07
0.08
5.2
2.0
—
—
—
0
0
6
58
1.03
0.08
1.8
1.9
18.17
20.83
nmol/l
—
6
49
5
64
0.78
0.08
1.0
1.9
78.42
104.26
ng/l
—
5
64
17
156
1.09
0.08
1.8
1.7
—
—
—
0
0
335
3315
1.02
0.07
4.0
3.2
—
—
—
0
0
16
148
1.08
0.06
3.3
2.5
—
—
—
0
0
79
808
0.98
0.05
2.1
2.4
8.17
7.25
ug/l
0.22
71
722
10
110
0.91
0.05
1.4
1.6
—
—
—
0
0
24
252
0.95
0.05
1.0
1.1
0.55
0.71
ratio
—
6
35
10
91
1.10
0.04
1.2
1.3
102516.00
165900.62
e6/l
—
5
60
28
272
1.03
0.02
4.1
1.8
—
—
—
0
0
12
113
1.06
0.02
2.3
1.2
—
—
—
0
0
45
457
0.98
0.01
4.4
3.9
—
—
—
0
0
30
306
0.98
0.00
1.0
1.1
—
—
—
0
0
26
265
0.98
0.00
1.0
1.2
1.51
1.53
g/l
0.18
26
265
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
18
180
1.00
-0.00
1.1
1.2
—
—
—
0
0
46
460
1.00
-0.00
2.4
3.8
1.02
1.02
ratio
1.23
40
433
0
7
0.00
-0.00
0.0
5.7
—
0.17
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
558.20
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
0.50
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
0.06
—
0
6
0
8
0.00
-0.00
0.0
1.6
—
365.13
—
0
8

Mortality – FinRegistry

↥

Association

Association between endpoint D3_BLOODNAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_BLOODNAS 2.238 [1.91, 2.63] < 0.001
Birth year 0.995 [0.99, 1.0] 0.245

During the follow-up period (1.1.1998 — 31.12.2019), 570 out of 2131 females with D3_BLOODNAS died.

Males

Parameter HR [95% CI] p-value
D3_BLOODNAS 2.256 [1.9, 2.67] < 0.001
Birth year 0.981 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 665 out of 1883 males with D3_BLOODNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_BLOODNAS.

N-year risk Females Males
1 0.227% 0.362%
5 1.374% 2.281%
10 3.61% 5.483%
15 6.907% 9.997%
20 11.592% 16.14%

Relationships between endpoints

↥

Index endpoint: D3_BLOODNAS – Other and unspecified diseases of blood and blood-forming organs

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data